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ABSTRACT 
 
 
 Chlamydia spp. are prokaryotic obligate intracellular pathogens with a unique, 
biphasic developmental cycle in which an infectious, extracellular form termed the 
elementary body (EB) interconverts with a metabolically active intracellular reticulate 
body (RB) within host cells.  Subsets of genes are differentially expressed during the 
developmental cycle, and these genes are believed to be responsible for the transitions 
between the EB and RB forms.  The goal of these studies was to explore two potential 
mechanisms that may function in regulating developmental cycle stage-specific gene 
expression in chlamydiae: a cascade of sigma factor expression and the binding of the 
early stage protein EUO to DNA.   
 
 The protein expression levels of each of the three sigma factors were monitored 
throughout the developmental cycle to determine if expression of the sigma factors is 
consistent with a role in directing temporal gene regulation via a cascade mechanism.  
Western blot and immunofluorescence assays revealed that the sigma 66, the major sigma 
factor, is present throughout the developmental cycle and, consequently, could direct 
temporal gene expression, but not via a simple cascade mechanism.   The alternative 
sigma 28 protein was found to be highest during the late logarithmic phase, and it can be 
speculated that it plays a key role in the initial stages of RB-to-EB conversion through its 
regulation of the late DNA binding protein, histone HctB.  Analysis of sigma 54 protein 
suggested it may exist in two forms:  a cytoplasmic form, which most likely functions as 
a sigma factor during RB replication, and an outer membrane complex form, which is 
present in RBs and EBs and may have a structural function.  Expression of the proposed 
functional sigma 54 protein throughout the logarithmic phase suggests that it plays no 
direct role in EB-RB differentiation via a cascade mechanism.  
 
 EUO is a DNA-binding protein that is produced early in the developmental cycle 
but is also present during the logarithmic phase of growth.  Because transcription studies 
have suggested that euo is the most actively expressed gene within the first few hours of 
infection, EUO is believed to be a potential transcriptional regulator.  A ChIP-to-Chip 
protocol was performed with isolated genomic DNA and recombinant EUO to identify 
genes to which EUO may bind.  DNA that co-immunoprecipitated with the recombinant 
EUO was allowed to hybridize to a microarray that contained the intergenic regions and 
the open reading frames of the Chlamydia trachomatis serovar D genome.  EUO binding 
was observed to be scattered throughout the genome, although with reproducible affinity 
for particular DNA fragments.  However, direct evidence for regulation of key 
stage-specific genes was not obtained by this study.  
 
An immunoprecipitation-cloning protocol was developed to identify in vivo 
binding sites of EUO.  Sixteen hour post-infection RBs were formaldehyde cross-linked 
to preserve the physiological interactions between native EUO and DNA.  EUO was 
immunoprecipitated from these cross-linked reticulate bodies and the EUO-bound DNA 
was cloned and sequenced.  BLAST searches of these sequences identified thirty genes 
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that may be in vivo targets of EUO, but the role of these genes in EB-RB interconversion 
is unclear.   
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CHAPTER 1.    INTRODUCTION 
 
 
CHLAMYDIA NOMENCLATURE AND DISEASE  
 
Species of the genus Chlamydia are prokaryotic obligate intracellular bacteria 
with a wide host tropism that cause an array of diseases in humans and animal, including 
the most common preventable sexually transmitted disease in the United States.  The 
National Institute of Allergy and Infectious Diseases reports 4 to 8 million new cases 
Chlamydia trachomatis infections occur each year (1999).  In the United States, the direct 
medical cost of chlamydial sexually transmitted disease was estimated to approach 30 
million dollars annually, with the incidence of 5259 infections per 100,000 people in 
2006 (Pultorak, Wong et al. 2009).  The consequences of these chlamydial infections are 
estimated to indirectly cost the United States more than 2 billion dollars annually (Stamm 
1999), and these figures do not take into account the population of men and women who 
are asymptomatic for the disease.  Chlamydiae pose a major problem on a global stage as 
well.  The World Health Organization (WHO) estimated that 92 million people were 
infected with chlamydiae around the world in 1999.  C. trachomatis is the causative agent 
of trachoma, the leading cause of preventable blindness in the world, having the greatest 
impact on developing countries (Resnikoff, Pascolini et al. 2004).  The World Health 
Organization has initiated a program in an attempt to eradicate blinding trachoma by the 
year 2020 (Negrel and Mariotti 1998). 
 
The order Chlamydiales contains the families Chlamydiaceae, 
Parachlamydiaceae, Waddliaceae, and Simkaniaceae (Bush and Everett 2001).  The 
family Chlamydiaceae is divided into two genera, Chlamydia and Chlamydophila based 
on phylogenetic analysis of the 16s and 23s rRNA.  However, most investigators in the 
Chlamydia research field dispute the splitting of the genus (Stephens, Myers et al. 2009) 
and the single genus name Chlamydia is commonly accepted in publications.  There are 
nine species in the Chlamydia genus: C. muridarum, C. trachomatis, Chlamydia suis, C. 
abortus, C. caviae, C. felis, C. pecorum, C. pneumoniae, and C. psittaci (Everett, Bush et 
al. 1999).   
 
 Three of the nine species of Chlamydia are known to cause disease in humans.  C. 
psittaci is the causative agent of psittacosis.  Although it is avian in nature, continuous 
exposure to infected birds or bird droppings can cause the transmission of the pathogen to 
a human host.  Psittacosis can range from an inapparent sickness to severe pneumonia, 
endocarditis, and encephalitis.  Although outbreaks of psittacosis have declined, some 
regions of the world are experiencing an increase in incidence rates (Andersen and 
Vanrompay 2000).  The incubation time of C. psittaci in humans ranges between one to 
four weeks.  The symptoms usually are present around day ten.  Tetracycline and 
chloramphenicol are administered to patients with psittacosis.  The Center for Disease 
Control has labeled C. psittaci as a category B biological weapons agent. 
 
 Chlamydia pneumoniae is a common cause of upper respiratory infections and 
pneumonia in humans.  It is estimated to cause up to ten percent of the community-
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acquired pneumonia and five percent of bronchitis and sinusitis cases (Aldous, Grayston 
et al. 1992).  It affects all age groups but is most common amongst the elderly and 
children between the ages of five and fourteen years of age (Grayston 1992). The Center 
for Disease Control estimates that there are two to five million cases of pneumonia 
annually resulting in half a million hospitalizations.  Azithromycin or clarithromycin are 
the primary antibiotics administered for treatment of pneumonia caused by C. 
pneumoniae.  C. pneumoniae has also been shown to be associated with chronic coronary 
heart disease, acute myocardial infarction (Saikku, Leinonen et al. 1988) and asthma 
(Hahn, Bukstein et al. 1998). 
 
 Chlamydia trachomatis is the third species that commonly causes disease in 
humans.  It is a major agent of ocular infections such as trachoma and infant inclusion 
conjunctivitis or can be the cause of sexually transmitted diseases such as urethritis, 
cervicitis, epididymitis, and pelvic inflammatory disease.  C. trachomatis is divided into 
three different biovars: trachoma, lymphogranuloma venerum (LGV), and mouse 
pneumonitis.  The biovars, trachoma and LGV, have been sub-classified into serovars A-
K and L1, L2, and L3, respectively (Wang, Kuo et al. 1985), with the addition of serovars 
Da, Ia, and L2a in 1991 (Wang and Grayston 1991).  Serovars A-C are responsible for 
the ocular infections such as trachoma.  Serovars D-K are responsible for infections in the 
genital tract.  The L serovars cause LGV, which is invasive and leads to the infection of 
the lymphatics and lymph nodes.  As the organism travels through the lymphatic system, 
it multiplies in the mononuclear phagocytes of the lymph nodes.  A breakout of LGV in 
the Netherlands in 2004 amongst men who have sex with men has led to a dissemination 
of the disease in Europe and the United States (Kivi, Koedijk et al. 2008). 
 
 
DEVELOPMENTAL CYCLE 
 
 Chlamydiae are intracellular pathogens with a unique biphasic developmental 
cycle (Moulder 1982).  The infectious, extracellular form of chlamydiae is known as the 
elementary body (EB).  It is an electron-dense structure measuring 0.3 micrometers in 
diameter.  EBs are osmotically stable, in part to the extensive cross-linking of their cell 
walls (Tamura, Matsumoto et al. 1971) and possess a condensed nucleoid structure which 
is compacted by histone-like proteins (Perara, Ganem et al. 1992).  The EB also contains 
surface projections that are anchored to the cytoplasmic membrane (Matsumoto 1982).  
Once internalized inside the host cell, the EB differentiates to the replicative, 
metabolically active form known as the reticulate body (RB).  The RB is larger in size 
than the EB, measuring one micrometer in diameter.  The RB also lacks the extensive 
cross-linking of the outer membrane as seen within the EB  (Hatch, Miceli et al. 1986).  
In this form, chlamydiae begin to grow and replicate via binary fission within a vacuole 
called an inclusion.  Through an unknown mechanism, the inclusion evades fusion with 
lysosomes.  After a period of growth and replication, a yet-to-be-established signal 
triggers the RBs to differentiate back into EBs; the EBs are then released from the cell 
and begin another round of infection.  
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Attachment 
 
The initial step of infection is the attachment of the EB to the outer surface of the 
host cell.  The process of attachment has been widely studied, although a definitive 
mechanism has yet to be elucidated.  Several factors, both of host and chlamydial origin, 
play a possible role in the attachment process.  Kuo and Grayston observed in 1976 that 
the presence of heparin and heparin sulfate causes a loss in infectivity of C. trachomatis 
(1976).  Heparin is a member of the glycosaminoglycan (GAG) family, which consists of 
long unbranched polysaccharides comprised of repeating disaccharide moieties.  More 
recent analysis has also illustrated the importance of GAGs during a chlamydial 
infection.  Zhang and Stephens showed that using purified GAGs and GAG lyases 
inhibits infection by chlamydiae (1992). The infectivity of chlamydiae in the presence of 
heparin is also biovar and serovar specific.  The LGV biovar uses a heparin-inhibitable 
mechanism for attaching to host cells, whereas the trachoma biovar uses a heparin-
independent mechanism (Chen and Stephens 1997).  A separate study comparing the 
affects of GAGs on the infection rates of C. trachomatis serovars LGV and E showed that 
serovar LGV and not serovar E is dependent on host cell heparin sulfate (Taraktchoglou, 
Pacey et al. 2001).   In vitro studies have shown that heparin sulfate inhibits infection, 
and an in vivo study demonstrated the inability of several sulfated polysaccharides 
(heparin, dextran sulfate, and pentosate polysulfate) to provide a protective efficacy in a 
murine model of chlamydial genetic tract infection (Su and Caldwell 1998).  It has been 
proposed that the inhibitory effects of heparin may be a non-specific charge-mediated 
interaction and that other, more specific interactions must be present to complete the 
attachment process. 
 
Several chlamydial proteins have been identified as possible adhesion molecules 
that help the pathogen to attach to the host cell.  In an attempt to define surface 
components that may be a part in the attachment process, Su et al. treated EBs with 
trypsin and monitored its effect on infectivity (1988).  Trypsin proteolysis resulted in the 
cleavage of the major outer membrane protein (MOMP) and a loss in attachment and 
infectivity.  It was also noted that the cleavage of MOMP by trypsin was serovar-specific.  
There were two cleavage sites in serovar B MOMP but only one site in serovar L2 
MOMP.  The additional cleavage site in serovar B MOMP was concluded to be the major 
determinant in the loss of infectivity because the single cleavage site of serovar L2 was 
insufficient in causing the loss of infectivity.  Another protein that has been implicated as 
having a role in attachment is the cysteine-rich outer membrane complex B protein 
(OmcB).  OmcB elicits a strong antibody response, suggesting a surface localization 
(Wagels, Rasmussen et al. 1994).   It is conserved among all Chlamydia spp., thereby 
serving as a possible candidate for being an adhesion molecule of chlamydiae.  Using 
yeast-display technology where OmcB is presented on the surface of yeast, it was 
observed that these yeast cells were able to bind to human epithelial cells (Moelleken and 
Hegemann 2008).  In a different study, infectivity infection assays were carried out using 
recombinant OmcB protein and a decrease in infectivity was seen in both LGV and B 
serovars (Fadel and Eley 2008).  However, studies by the Hatch lab (Everett and Hatch 
1995) suggest that OmcB is located in the periplasm and is not surface exposed.  Failure 
to identify surface exposure has been confirmed by others (Watson, Lambden et al. 1994) 
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and the role of OmcB in attachment remains controversial.  Polymorphic membrane 
protein D (PmpD) is another highly conserved protein that has been implicated as a 
possible adhesion.  Addition of antibodies raised against PmpD resulted in a decrease of 
infectivity of EBs (Wehrl, Brinkmann et al. 2004).  Several other chlamydial proteins 
have been shown to play a role in the attachment process, but a definitive attachment 
mechanism has yet to be elucidated. 
 
 The attachment process of a pathogen not only depends on virulence factors from 
the pathogen but also is dependent on host cell determinants.  Researchers have shown 
that the chlamydial attachment process is protein disulfide isomerase dependent (PDI) 
(Conant and Stephens 2007).  In this study, Chinese Hamster Ovary 6 (CHO6) was used 
to monitor the attachment of C. trachomatis.  CHO6 cells are normally resistant to 
chlamydial attachment and entry due to CHO6 cells having a defect in processing the 
leader sequence for protein disulfide isomerase, causing it to be inactive.  
Complementation of the full-length protein disulfide isomerase resulted in the ability of 
C. trachomatis to attach and enter the host cell.  The Wyrick lab (Davis, Raulston et al. 
2002) also demonstrated that chlamydial attachment is dependent on the reduction of the 
EB cross-linked outer membranes.  They treated human endometrial epithelial cells with 
PDI inhibitors at the time of EB attachment which resulted in reduced chlamydial 
infectivity.  From the many studies performed and the various factors which have been 
shown to play a role in the attachment of chlamydia to the target cell, it would appear that 
attachment is a multi-step process.   
 
 
Entry 
 
Following attachment to the host cell, the EB is then taken up into the host cell 
via endocytosis.  The details of the mechanism behind the uptake of EBs have been 
debated.  Early studies suggested that the EB enters the target cell via clathrin-coated pits 
(Hodinka and Wyrick 1986).  The Wyrick lab demonstrated that C. trachomatis entered 
polarized epithelial cells through clathrin-mediated endocytosis (Wyrick, Choong et al. 
1989).  Majeed et al. utilized immunofluorescence to monitor the distribution and 
localization of EBs, F-actin, and clathrin in cells infected with chlamydiae.  It was 
observed that polymerized actin and clathrin played a role in the redistribution of 
chlamydiae into an intracellular aggregate (Majeed and Kihlstrom 1991).  Some reports 
have observed chlamydia being endocytosed in vesicles void of clathrin (Murray and 
Ward 1984).   Norkin et al. (2001) examined the possibility of EBs being endocytosed in 
a caveolae-mediated pathway and similarities were observed between the entry of 
chlamydiae and a caveolae-mediated pathway mediated by simian virus 40 (SV40).  C. 
trachomatis serovar K was noted to enter three different cell types via caveolin-
containing sphingholipid and cholesterol-enriched raft microdomains of the cell plasma 
membranes.  C. trachomatis serovars E and F, C. psittaci, and C. pneumoniae were also 
seen to enter the cell in a similar fashion (Stuart, Webley et al. 2003).  The Stuart et al. 
study also showed that C. trachomatis serovars A, C, L2, and mouse pneumonitis (MoPn) 
entered the cell via a caveolin-independent manner, raising the possibility that the method 
of entry may vary from one strain/species of Chlamydia to another.  Further evidence of 
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this is the association of the chlamydial inclusion with the host protein, calveolin-2.  
Calveolin-2 and not calveolin-1 was seen to associate with inclusions of C. trachomatis 
serovars A, B, and C (Webley, Norkin et al. 2004).  A more recent study used RNA 
interference to disrupt the production of proteins involved in either clathrin-mediated, 
caveola-mediated, phagocytosis, and macropinocytosis mechanisms of endocytosis 
(Hybiske and Stephens 2007).  The outcome of this study was that clathrin-mediated 
endocytosis was responsible for the entry of chlamydial EBs, although other additional 
mechanisms may also have a role in uptake.   
 
One of the additional mechanisms proposed was a chlamydial type III secretion-
effector molecule, translocated actin-recruiting phosphoprotein (TARP), inducing 
chlamydial entry into the cell.  TARP was discovered when a unique tyrosine-
phosphorylated protein was identified in infected cells and this protein increased in 
abundance with a concomitant increase in the multiplicity of infection (Clifton, Fields et 
al. 2004).  This protein was absent in uninfected cells and was seen to be 
unphosphorylated in purified EBs.   TARP localizes to the inside of the host plasma 
membrane at the site of chlamydial attachment and there it is phosphorylated resulting in 
the recruitment of actin to the site of infection.  TARP phosphorylation was later seen not 
to be necessary in the recruitment of actin (Clifton, Dooley et al. 2005).  C. muridarium, 
C. caviae, and C. pneumoniae TARP all lack the N-terminal phosphorylation domain yet 
were able to induce actin recruitment upon infection, leading Clifton et al. to propose that 
the C-terminal region of the protein was responsible for actin recruitment.  They 
suggested that TARP, though proposed to play a role in actin recruitment, may indirectly 
activate signal transduction pathways.  Differences in the signal transduction pathways 
have been noted between chlamydial species (Moulder 1991) and the phosphorylation of 
TARP in C. trachomatis and not C. muridarium, C. caviae, and C. pneumoniae may be 
another example of varying mechanisms of signal transduction between chlamydial 
species.  Antibodies to C. trachomatis TARP have been shown to induce protective 
immunity in upper genital infections of mice (Wang, Chen et al. 2009).  TARP is one of 
several type III secretion-effector molecules produced by chlamydiae and since the 
discovery of a contact-dependent secretion apparatus in chlamydiae, (Hsia, Pannekoek et 
al. 1997), many studies have investigated the possible roles type III secretion machinery 
plays in respect to a chlamydial infection.   
 
 
Intracellular Adaptation and Survival 
 
 Once an EB enters its target cell, several processes begin to aid its survival, 
differentiation, and growth.  The initial objective of the EB is to avoid targeting by the 
lysosomal fusion pathway.  Viruses and bacteria, when engulfed by a eukaryotic cell, are 
typically transported to the lysosome for digestion.  As an intracellular pathogen, 
chlamydia must subvert this targeting to the lysosome to ensure its survival and 
subsequent growth in this environment.  The chlamydial inclusion does not exhibit a drop 
in pH, which is one of the initial steps in vesicles being targeted to the lysosome 
(Schramm, Bagnell et al. 1996).  An early study (Friis 1972) noted that chlamydial 
escape from the lysosomal degradation pathway was dependent on live, intact 
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chlamydiae.  This lab also reported that heat-inactivated C. psittaci was phagocytized by 
L cells and was targeted for digestion by the lysosome (Friis 1972).  However, protein 
synthesis by the bacteria was not necessary for prevention of lysosomal degradation, as 
evidenced by the ability of chlamydiae to escape targeting to the lysosome in the 
presence of chloramphenicol.  This study concluded that entering EBs intrinsically 
contain factors that abrogate its digestion via the lysosomal pathway.  A later study 
confirmed that the addition of chloramphenicol has no immediate effect on the ability of 
chlamydiae to avoid targeting to the lysosome to EB-containing vacuoles but that 
ultimately fusion occurs and EBs are degraded (Scidmore, Fischer et al. 2003).  
Eissenberg and Wyrick (1981) investigated whether escape from the phagolysosomal 
pathway was restricted to the EB-containing vacuole or was the result of a general 
paralysis of fusion within the infected cells.  They found that co-infection of a 
macrophage with C. psittaci and Saccharomyces cerevisiae resulted in degradation of the 
yeast cell but not the EB, concluding that chlamydiae most likely make modifications to 
their inclusion membrane to avoid the lysosomal degradation pathway.   
 
The identification of proteins localized to the inclusion membrane further proved 
the notion that chlamydiae modify their inclusion membrane to ensure its survival as 
intracellular bacteria.  The Rockey lab used sera from guinea pigs infected with C. 
caviae, the agent of guinea pig inclusion conjunctivitis (GPIC), to probe by western blot 
lysates from both infected HeLa cells and isolated EBs to observe any differences in 
antigens between them (Rockey and Rosquist 1994).  Three proteins, referred to as p22, 
p34, p52 (based on their molecular weights) were identified in the infected HeLa cells but 
absent from purified EBs and uninfected HeLa cells.  It was concluded that these proteins 
are produced by chlamydiae and transported to the inclusion membrane during 
intracellular growth.  A follow-up study used antisera from C. psittaci-infected animals to 
determine the cellular localization of a 39-kilodalton protein that was present in infected 
HeLa cells and not EBs.  Using fluorescent microscopy, this protein was found in the 
inclusion membrane but absent from the developmental forms within the inclusion 
(Rockey, Heinzen et al. 1995).  The protein was named inclusion membrane A (IncA).  
Other studies have observed and identified other inclusions-specific proteins: IncB, IncC 
(Bannantine, Rockey et al. 1998), IncD, IncE, and IncF, and IncG (Scidmore-Carlson, 
Shaw et al. 1999).  Banantine et al. found that all known Inc proteins contain a similar 
hydrophobicity domain and took advantage of this characteristic motif to scan the C. 
trachomatis genome to identify any other potential Inc proteins (Bannantine, Griffiths et 
al. 2000).  Forty-six potential Inc proteins were identified by this survey.  Six possible 
candidate Inc proteins were examined to see if they localized to the inclusion membrane 
and five of the six proteins were confirmed to be Inc proteins. Further studies need to be 
performed to analyze the remaining proteins that were identified to observe if they are 
targeted to the inclusion membrane.  
 
Other proteins that lack the hydrophobicity domain characteristic of the Inc 
proteins have also been found to be localized to the inclusion membrane.  Luo et al. 
expressed several hypothetical proteins of the C. pneumoniae genome as a fusion protein 
with Glutathione-S-transferase (GST) and used these fusion proteins to generate 
antibodies in mice (2007).  These antibodies were used to probe infected cells to visualize 
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the localization of the corresponding protein.  By confocal microscopy, the hypothetical 
protein, cpn0308, was seen to localize to the inclusion membrane.  Western analysis 
identified a band only in C. pneumoniae-infected cells and not mock-infected or cells 
infected with C. trachomatis, which does not encode this protein. CT813, was also 
identified in this manner (Chen, Chen et al. 2006).  CT813 is highly immunogenic, as 
evident by high titers of antibody recognizing the protein being produced from women 
who are urogenitally infected with C. trachomatis.  CopN, a type III secretion-effector 
molecule, was also found to be localized to the inclusion membrane by indirect 
immunofluorescence.  Heterologous expression of CopN from C. pneumoniae in both 
yeast and mammalian cells resulted in cell cycle arrest via disruption of the microtubule 
network (Huang, Lesser et al. 2008).    
 
Some host cell proteins have been seen to be associated with the inclusion 
membrane.  The small GTPases Rab6 and Rab11 have been observed to be associated 
with the chlamydial inclusion (Rejman Lipinski, Heymann et al. 2009), with Rab11 
colocalizing with the chlamydial protein IncG on the inclusion surface.  
Oculocerebrorenal syndrome of Lowe protein (OCRL1), a phosphatidylinositol 5-
phosphate that binds Rab GTPases also translocates to the chlamydial inclusion 
membrane (Moorhead, Jung et al. 2010).  Immunofluorescence staining with antibodies 
revealed that annexin III, annexin IV, and annexin V all migrate to the proximity of the 
chlamydial inclusion (Majeed, Ernst et al. 1994).  Members of the Src family of kinases 
are also targeted to the inclusion membrane during an infection (Mital, Miller et al. 
2010).  It is evident that proteins that are translocated to the chlamydial inclusion 
membrane are capable of interacting with host cell components, and the analysis of these 
proteins and their interactions may uncover specific processes that may be responsible for 
the pathogenesis of chlamydiae. 
 
Within two hours of EBs entering into the host cell, the chlamydial inclusion is 
trafficked to the peri-nuclear region of the cell.  Several studies have looked at the 
mechanisms that are responsible for targeting chlamydiae to this region, and it appears 
that the host cytoskeleton is a major factor in this process.  One study observed the 
aggregation of F-actin and clathrin with inclusions, and this aggregation was severely 
disrupted with the addition of cytochalasin-D (Majeed and Kihlstrom 1991).  
Cytochalasin-D is a mycotoxin that inhibits actin polymerization. Using indirect 
immunofluorescence microscopy, Clausen et al. observed the co-localization of the host 
microtubule network with chlamydia-containing vesicles as chlamydiae were being 
trafficked to the peri-nuclear region of the cell (Clausen, Christiansen et al. 1997).  It was 
later observed that the minus-ended microtubule motor, dynein, was responsible for this 
movement towards the microtubule-organizing center (MTOC) (Grieshaber, Grieshaber 
et al. 2003).  Microinjection of antibodies directed towards a subunit of the dynein motor 
resulted in the abrogation of trafficking of chlamydia-laden vesicles to the MTOC, 
whereas antibodies that were raised towards the positive-end motor, kinesin, had no 
affect on this process.  It was also noted that both chlamydial transcription and translation 
were needed in this trafficking process due to the inhibition of migration with the 
addition of chloramphenicol, an inhibitor of bacterial translation, and rifampicin, an 
inhibitor of bacterial transcription.  This phenomenon suggests that the inclusion 
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membrane must be modified or that an effector molecule produced by chlamydiae is 
imperative to achieve migration to the MTOC.  
 
 As obligate intracellular bacteria, chlamydiae require nutrients and metabolites 
from the host cell to ensure their growth and development.  Moulder dubbed chlamydiae 
energy parasites that depend on the host cell for energy intermediates for the production 
of macromolecules (Moulder 1962).  Tribby and Moulder demonstrated that chlamydiae 
use exogenous bases and ribonucleosides and incorporate them into their RNA and DNA 
during their developmental cycle (Tribby and Moulder 1966).  The energy parasite 
hypothesis was further strengthened by Hatch when he noted that chlamydiae take up 
purine and pyrimidine nucleoside triphosphates from the host pools (Hatch 1975).  It was 
also observed that thymidine uptake into chlamydia was dependent on host thymidine 
kinase activity (Hatch 1976).  The specific mechanism by which chlamydiae obtain ATP 
was identified by Hatch and coworkers (1982).  They found that RBs purified from 
infected host cells (host-free chlamydiae) use an ATP-ADP translocation system similar 
to that of mitochondria but in the opposite direction: ATP from the host cell cytoplasm to 
RBs rather than from mitochondria to the host cell cytoplasm.  The Hatch lab also 
demonstrated that GTP is incorporated into chlamydial RNA by host-free RBs in the 
presence of ATP (Crenshaw, Fahr et al. 1990).  Tipples and McClarty (1993) 
demonstrated that specific NTP requirements vary among Chlamydia spp.  They found 
that C. caviae is auxotrophic for ATP, GTP, and UTP but can either obtain CTP from the 
host directly or convert UTP into CTP, whereas C. trachomatis obtains all four NTPs 
from the host for growth.  Sequencing of the C. trachomatis genome confirmed the 
existence of two NTP transport systems (Stephens, Kalman et al. 1998).  One of the 
mechanisms ultimately was shown to be the ADP-ATP translocation system first 
identified by Hatch et al. (1982), and the other was demonstrated to be the mechanism by 
which net uptake of ATP, CTP, GTP, and UTP is accomplished at the expense of ATP 
obtained by the translocation mechanism (Tjaden, Winkler et al. 1999).  Interestingly, 
genome sequencing also revealed that chlamydiae are theoretically capable of generating 
some ATP by catabolism of glucose-6-phosphate.  However, the existence of two NTP 
transport mechanisms suggests chlamydiae are at least partially dependent on host NTPs 
at some stage during the developmental cycle and, consequently, are energy parasites. 
 
Sphingomyelin, a sphingolipid comprised of a ceramide core and 
phosphorylcholine side chain, is also taken up by chlamydiae (Hackstadt, Scidmore et al. 
1995).  In an effort to identify any interactions, cells were labeled with a Golgi-specific 
probe and monitored for any interactions between the chlamydial inclusion and the Golgi 
apparatus.  It was then observed that sphingomyelin was translocated to the chlamydial 
inclusion and was eventually incorporated into the cell wall of the chlamydiae.  Brefeldin 
A, a compound that disrupts retrograde transport from the Golgi to the Endoplasmic 
Reticulum (ER), abrogated the uptake and incorporation of sphingholipid into 
chlamydiae.  Therefore, it was surmised that the chlamydial inclusion interrupts the 
natural exocytic pathway that normally targets sphingomyelin to the plasma membrane 
from the Golgi network.  Glycoproteins, such as the vesicular-stomatitis virus G-protein, 
transferrin receptor, and human histocompatibility leukocyte class I antigen, were found 
not be translocated to the chlamydial inclusion (Scidmore, Fischer et al. 1996).  Thus, 
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there seems to be some specificity in which vesicles leaving the Golgi apparatus are 
selected and incorporated into the chlamydial inclusion.  Chlamydiae also contain 
eukaryotic glycerophospholipids in their cell membrane, but discovering how they 
acquire these glycerophospholipids has been problematic.  Neither treatment with 
Brefeldin A nor growing chlamydiae in mutant cells that lacked a lipid transfer protein 
abrogated the ability of chlamydiae to incorporate these eukaryotic glycerophospholipids 
into their membrane (Wylie, Hatch et al. 1997).  More recently it has been observed that 
cytoplasmic lipid droplets are translocated to the lumen of the chlamydia inclusion 
(Cocchiaro, Kumar et al. 2008).  These liquid droplets dock on the inclusion membrane, 
penetrate the membrane, and eventually begin to associate with RBs.  This process was 
found to be dependent on the chlamydial proteins IncA and Lda3.  This process 
represents a unique mechanism of organelle sequestration by an intracellular pathogen. 
 
 
Intracellular Growth and Development 
 
 Once the chlamydial EBs enter a host cell and evade the host cell defenses, they 
reorganize to the replicative RB stage.  The expression of chlamydial transcripts can be 
seen as early as one hour post-infection (Wichlan and Hatch 1993), and the expression of 
chlamydial proteins was observed as early as fifteen minutes post-infection (Plaunt and 
Hatch 1988).  Most genes are expressed during the logarithmic phase and are considered 
to be constitutively expressed.  Other genes are highly expressed at particular time points 
of the developmental cycle and are considered to be stage-specific.  Several investigators 
have studied this differential pattern of gene expression in an attempt to further 
understand the genetic events responsible for the interconversion between the two forms 
of chlamydiae.  Investigators used RT-PCR analysis on genes that were key components 
in essential biochemical pathways in an attempt to categorize the expression of genes 
(Shaw, Dooley et al. 2000).  Seventy genes from various pathways were selected and the 
initiation of transcription of these genes could be categorized into three temporal classes: 
early stage (transcripts detectable by two hours post-infection), middle stage (transcripts 
not detectable at two hours but appeared by twelve hours post-infection), or late stage 
(transcripts detected after twelve hours post-infection).  Although this study was 
successful in categorizing the selected genes into three different temporal classes; it only 
accounted for only eight percent of the genes of the C. trachomatis genome.  Later 
studies would provide a more thorough examination of genetic expression in C. 
trachomatis. 
 
 Nicholson et al. performed whole genome DNA-microarray expression profiling, 
using transcripts produced throughout the developmental cycle, to monitor the expression 
of 875 C. trachomatis chromosomal genes (2003).  They observed twenty-two percent of 
the C. trachomatis genome was temporally regulated. This group categorized the 
expression of genes into three stages.  Stage I, contained genes that are expressed by 
twelve hours post-infection and also included the constitutively active genes.  Seventy-
two percent of the chlamydial genome is within this cluster of genes.  The prototypic 
early gene, EUO, and genes responsible for DNA transcription, transport, and energy-
compound acquisition were found in this cluster.  Stage II genes were defined as genes 
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that transcripts increased significantly by eighteen hours post-infection.  At this point 
during the cycle, RB division is at maximal levels, with few RBs differentiating back to 
the EB form.  This cluster is comprised of genes responsible for envelope biogenesis, 
energy metabolism, type III secretion, protein folding, and DNA 
modification/recombination/repair.  Stage III was defined as genes that are not expressed 
until twenty-four hours post-infection.  At this point in the developmental cycle most RBs 
have reorganized to EBs or are in the process of reorganization and are preparing for exit 
from the host cell in order to begin another round of infection.  Hypothetical proteins 
comprise a significant portion of genes in this group.  Other genes in this cluster encode 
the cysteine-rich outer membrane proteins OmcA and OmcB, DNA gyrase paralogue 
(CT660), an orthologue of a type III secretion regulator (lcrH), and histone-like protein 
HctB that aids in condensing the chromosome.  Major criticisms of this study are (1) 
critical early time points when EBs convert to RBs (within the first 5 to 10 hours of 
infection) were not examined; (2) RNA was isolated from purified RBs rather than 
infected cells, thereby possibly missing unstable RNA species; (3) RNA was not properly 
normalized to chlamydial DNA content. 
 
 A later study also used microarray analysis to monitor the temporal regulation of 
genes throughout the developmental cycle of C. trachomatis, but used considerably more 
sophisticated controls, examined very early times points, and corrected for residual late 
stage transcripts present in infecting EBs; this study remains the benchmark for the 
identification of stage-specific genes in chlamydiae (Belland, Zhong et al. 2003).  Major 
contributions of the Belland group include identification of immediately early stage genes 
and the importance of differential tryptophan synthesis genes and EUO gene expression 
during interferon gamma-induced persistence during the developmental cycle.  The 
mechanisms that regulate temporal expression of chlamydial genes are an ongoing focus 
in the field. 
 
 
Exit 
 
 The final step in the chlamydial developmental cycle is release from the host cell.  
Using live imaging of McCoy cells infected with C. trachomatis serovar E to monitor the 
nature of the chlamydial inclusion during interphase and mitosis, researchers set out and 
observed the lysis of the host cells at seventy-two hour post-infection (Campbell, 
Richmond et al. 1989).  Similarly, C. trachomatis infection of the primary cell cultures of 
the human amnion resulted in the rupture of host cells at late times in the infection 
(Neeper, Patton et al. 1990).  Investigators  (Rockey, Fischer et al. 1996) evaluated C. 
psittaci inclusions during an infection and noticed the lysis of the inclusion, followed by 
the infectious EBs occupying the cell cytoplasm, then the final step of cell lysis and the 
escape of the EBs to begin another round of infection.  This study also noted that one of 
the lobes of the chlamydial inclusion escaped from the cell before lysis, indicating that 
chlamydia may possess multiple mechanisms of escape from the host cell.   
 
Other studies have noted chlamydiae escaping the host cell by a means other than 
lysis.  Fluorescent-antibody staining of HeLa cells infected with C. trachomatis serovar D 
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showed that the release of chlamydiae from the cell was not concomitant with the death 
of the cell.  Ultrastructural studies showed the chlamydial inclusion was transported to 
the host cell surface via a process similar to exocytosis (Todd and Caldwell 1985). 
Another group (Hybiske and Stephens 2007) examined the method of release by taking 
advantage of the ability of chlamydial inclusions to exclude large, soluble fluorescent 
markers.  They stably expressed green fluorescent protein (GFP) in HeLa cells thereby 
making the chlamydial inclusions visible via live fluorescence microscopy and reached 
the conclusion that EB release occurs via one of two mechanisms: by lysis of the host cell 
or by a packaged release called extrusion.  Cellular regulators of both the cell lysis and 
the extrusion pathways were identified in this study.  Cell lysis was dependent on calcium 
signaling within the cell, and treatment of the cell with protease inhibitors abrogated the 
lysis process.  Extrusion required actin polymerization, myosin II, and Rho GTPase.  
Similar to the attachment process, it is likely that different species of Chlamydia use 
different mechanisms to exit host cells and that method of exit may vary with 
environmental conditions even within a given species. 
 
 In summary, the chlamydial developmental cycle begins with the attachment of 
the EB to the target cell and entry into cytoplasm by only partially understood 
mechanisms that resemble endocytosis and which include avoidance of the nascent 
inclusion into the lysosomal pathway.  Within a few hours, possibly a few minutes, the 
EB initiates early gene expression necessary for conversion to RBs, which divide by 
binary fission.  After growth and division RBs convert back to EBs which are released by 
multiple mechanisms to infect new cells.  All of these processes require chlamydiae to 
express genes in an organized manner.  The environmental signals which trigger stage-
specific expression and the mechanisms by which stage-specific regulation is 
accomplished are topics at the forefront of chlamydial research. 
 
 
GENE REGULATION 
 
 The mechanisms by which temporal gene expression is regulated in chlamydiae is 
poorly understood.  However, several mechanisms of chlamydial gene regulation in 
general have been elucidated. 
 
 
Promoters and Sigma Factors 
 
 Because chlamydiae progress through morphologically distinct developmental 
stages (in the very simplest terms: EB-to-RB, early stage; RB cell division, middle stage; 
RB-to-EB, late stage), it follows that chlamydial gene expression is temporally regulated.  
The first specific gene products demonstrated to be stage-specific were two cysteine-rich 
proteins (CRPs), now known to be encoded by an operon designated omcAB.  The CRPs 
were identified by SDS-PAGE analysis in EBs but not in dividing RBs (Hatch, Allan et 
al. 1984).  In 1986, two additional EB-specific proteins, now known to be positively 
charged histone-like proteins HctA and HctB, were reported to bind to negatively 
charged host cell membranes and speculated to be chlamydial adhesins (Hackstadt 1986).  
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In the absence of a tractable genetic system and prior to sequencing of the late-stage 
encoding genes, regulatory mechanisms responsible for stage-specific expression could 
only by speculated.  In other bacteria, stage-specific and environmentally induced 
expression of genes is often accounted for by the expression of different sigma factors.  
Sigma factors bind to the RNA polymerase and enable it to preferentially bind specific 
promoter sequences.  Bacteria may possess multiple sigma factors, as found in B. subtilis, 
S. coelicolor, and cyanobacteria, that function in a cascade-like fashion to differentially 
regulate genes during their developmental cycles (Gruber and Gross 2003).  A particular 
sigma factor may be responsible for the regulation of other sigma factors, thereby 
initiating a “cascade” of sigma factor expression.  Even before any chlamydial sigma 
factors were identified, a “sigma cascade” was a favored hypothesis for temporal 
expression in chlamydiae.   
 
  The first chlamydial sigma factor to be identified was designated sigma 66 on the 
basis of its molecular mass.  Upon sequencing, the sigma 66 gene (rpoD) was observed to 
encode a protein highly homologous in amino acid sequence to the major sigma factors of 
E. coli (sigma 70) and B. subtilis (sigma 43) (Koehler, Burgess et al. 1990).  Sigma 66 
was found to be present in RBs and EBs and consequently deemed to initiate the 
expression of “house-keeping” genes, as is the case for sigma 70-like factors in other 
bacteria.   
 
 The first chlamydial gene to be cloned and sequenced was ompA, encoding the 
major outer membrane protein (MOMP) (Stephens, Kuo et al. 1985).  Putative promoters 
were identified upstream of the two MOMP gene transcripts, neither of which were found 
to be expressed in E. coli.   This led to the premature conclusion that chlamydial 
promoters were “different” from other bacterial promoters (Stephens, Wagar et al. 1988).  
However, 5’end analysis of two chlamydia cryptic plasmid transcripts, both with the 
same 5’end, revealed near-consensus like -10 and -35 promoter elements (TTGCCA and 
TATATT, respectively) (Fahr, Sriprakash et al. 1992).  Investigators (Douglas, Saxena et 
al. 1994) developed a chlamydial in vitro transcription system using the plasmid template 
cloned into a transcription assay vector, and later in vitro studies confirmed that 
recombinant sigma 66 recognizes the most distal ompA promoter (Fahr, Douglas et al. 
1995).  The translation start site proximal transcript, with only GC-rich upstream 
sequence, was determined to be a post-transcriptional product of the long transcript.  In 
vitro mutagenesis coupled with in vitro transcription analysis found that whereas the 
ompA promoter (-10: CACAAA) is not recognized by E. coli sigma 70, promoter 
sequences more closely resembling the bacterial consensus (-10:  TATAAT) are also 
efficiently recognized by recombinant sigma 66.  An exhaustive in vitro mutagenesis-in 
vitro transcription study of the rRNA operon by Tan and Engel (1996) confirmed that the 
preferred Sig66 promoter -35 and -10 sequences are identical to the E. coli sigma 70 
consensus (TTGACA and TATAAT), although sigma 66 is clearly more promiscuous 
than other bacterial major sigma factors (Mathews and Sriprakash 1994).  Several other 
genes, not considered to be cycle-specific, have been experimentally shown by in vitro 
transcription analysis to be controlled by either sigma 66 or recombinant E. coli sigma 
70:  the kdsA gene (Brabetz and Brade 1997), the tuf gene (Shen, Shi et al. 2000), the 
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dnaK gene (Schaumburg and Tan 2003), and the genes of the type III secretion system 
(Hefty and Stephens 2007). 
 
 A total of three sigma factors, sigma 66, sigma 28, and sigma 54, were identified 
upon sequencing the chlamydia genome, lending strength to the hypothesis that a sigma 
cascade, most likely sequential expression of sigma 54/sigma 28, might be responsible 
for temporal gene regulation in chlamydiae (Stephens, Kalman et al. 1998).   Sigma 54 
and sigma 28 are found in many bacteria, and the genes they regulate differ depending 
upon the bacterial species.  These alternative sigmas have yet to be implicated directly in 
the transcription of developmental genes in other bacteria, although activation of sigma 
54 in response to environmental stimuli has been shown to trigger stalk and fruiting body 
formation in Caulobacter and myxococcus, respectively (McCleary and Zusman 1990; 
Marques, Gomes et al. 1997). 
 
 Researchers used host-free generated RNA probes to identify late-stage specific 
genes, including the previously identified hctA and omcA and two new late genes 
designate ltuA and ltuB (Fahr, Douglas et al. 1995).  They identified the 5’ ends of these 
genes and also the remaining known late stage gene hctB and located likely promoters on 
the basis of homology to known bacterial promoter sequences; all of the predicted 
promoters most closely resembled the bacterial major sigma consensus.  They used a 
chlamydial in vitro transcription system, coupled with inhibitory anti-sigma 66, to 
demonstrate that all but hctB were under the control of sigma 66, erecting a significant 
barrier to sigma cascade hypothesis for late-stage gene expression.  A later group found 
that the Fahr et al. study had misidentified the transcription start site of hctB and 
presented evidence that transcription of this gene is initiated by sigma 28, re-kindling the 
idea of alternative sigma factors playing a role in at least late-stage gene regulation (Yu 
and Tan 2003). 
 
 Sigma 28 is responsible for the transcription of genes required for flagella 
biosynthesis (Helmann 1991) and chemotaxis (Mirel, Lustre et al. 1992) in other bacteria, 
but these genes are lacking in Chlamydia.  To identify potential sigma 28-regulated genes 
in chlamydiae, the genome was scanned for promoter sequences that resembled the 
canonical sigma 28 consensus sequence, since this sequence is highly conserved among 
bacteria (Yu and Tan 2003).  After scanning the genome, a sequence closely resembling 
the sigma 28 consensus was identified upstream of hctB.  Recombinant sigma 28 was 
produced and reconstituted in a chlamydial in vitro transcription system with which the 
expression of the hctB promoter region was assessed and found to be responsible for 
transcription from the predicted sigma 28 promoter.  Mutational analysis was also 
performed on the hctB promoter region in an effort to define the sequences that were 
optimal for sigma 28 binding and for the purpose of better predicting sigma 28 binding 
regions within the chlamydial genome (Yu, Di Russo et al. 2006).  One group later used a 
probability weight matrix based on known sigma 28 promoters of other bacteria with the 
new information they gathered from the mutational analysis of the hctB promoter to 
predict other possible sigma 28 regulated genes (Yu, Kibler et al. 2006).  Sixteen 
additional candidate genes were identified, but functional analysis via in vitro 
transcription showed only five of these candidate genes were actually under the control of 
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sigma 28: tsp, dnaK, tlyC_1, bioY, and pgk.  Primer extension analysis was used to 
validate the location of the putative sigma 28 promoters in vivo.  The genes hctB, tsp, and 
pgk mapped to within six nucleotides of 5’ ends, and dnaK mapped to within 10 
nucleotides of predicted start site.  Of these newly identified sigma 28 controlled genes, 
three of these genes are known to be expressed late within the developmental cycle: hctB, 
tsp, tlyC_1 (Belland, Nelson et al. 2003).  This would suggest that sigma 28 may regulate 
genes expressed late in the developmental cycle.  In contrast bioY, pgk, and dnak were 
seen in the Belland et al. study to be express early within the developmental cycle.   It 
was noted that the Belland et al. study monitored only the steady state transcription levels 
and would not be able to distinguish the temporal activity of genes with multiple 
promoters; pgk was regulated by sigma 28 and sigma 66 in this study and dnaK was 
regulated by sigma 28 in this study and sigma 66 in a previous study (Wilson and Tan 
2002).  So it is possible that sigma 28 regulation of genes is restricted to late time points; 
no other study has indicated that sigma 28 regulates genes expressed early during the 
developmental cycle. 
 
 In some bacteria, such as Salmonella and B. subtilis but not E. coli, sigma 28-like 
sigma factor activity is controlled by regulators.  These sigma factor regulatory proteins 
include RsbV, RsbW, and RsbU; all of which are encoded by Chlamydia spp., with the 
curious addition of a second RsbV protein.  The sigma regulators use a partner-switching 
mechanism to allow sigma 28 to bind or not bind RNA polymerase in response to 
environmental stimuli, usually some form of stress (Brown and Hughes 1995).  When 
RsbW binds to sigma 28, it prevents sigma 28 binding to RNA polymerase (Kang, Brody 
et al. 1996).  RsbV proteins are kinases that bind to RsbW and phosphorylate the protein; 
this phosphorylation inhibits the binding of RsbW to sigma 28.  RsbU is a phosphatase 
that dephosphorylates RsbW, thereby allowing RsbW to once again bind the sigma 28.  
In the absence of a usable genetic system, the chlamydial anti-sigma factors were 
examined in a heterologous system (Salmonella enterica serovar typhimurium) 
(Karlinsey and Hughes 2006).  Karlinsey and Hughes used C. trachomatis sigma 28 to 
complement a S. enteric sigma 28 mutant and assayed its activity by measuring motility.  
C. trachomatis sigma 28 was seen to complement the mutant strain and restored motility.  
This group introduced the C. trachomatis sigma 28 negative regulator, RsbW, in the 
system and observed that the sigma 28 activity was unaffected.  Hua et al. also examined 
the role of these conserved partner switching proteins by utilizing in vitro kinase 
reactions and yeast two-hybrid assays to assess the ability of these proteins to bind one 
another (2006).  They observed both RsbU and RsbW binding RsbV, but similar to the 
Karlinsey and Hughes study, they did not observe RsbW binding of sigma 28.  It was 
concluded that the chlamydial Rsb proteins may function in a manner similar to those in 
Bordetella.  Bordetella bronchiseptica contains the partner switching proteins BtrU, 
BtrV, and BtrW and the interactions between these proteins were examined (Kozak, 
Mattoo et al. 2005).  Generating mutations in serine 55 of BtrV (target of BtrW 
phosphorylation) and asparagine 51 of BtrW (pivotal for kinase activity) allowed this 
group to characterize the interactions between the two proteins.  Surprisingly, neither 
mutation affected the ability of these proteins to bind.  Using these mutations of BtrV and 
BtrW, they then monitored their effects on the type III secretion apparatus of Bordetella.  
It has been reported in Bordetella that the deletion of btrV or btrW (Mattoo, Yuk et al. 
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2004) results in the disruption of polypeptides being excreted through the type-III 
secretion apparatus.  Each mutation of BtrV and BtrW resulted in the inability of the 
type-III secretion apparatus to secrete proteins.  They proposed that phosphorylation of 
BtrV by BtrW is essential for the activation of the type-III secretion machinery and once 
BtrW disrupts its binding with BtrV by phosporylating the protein, it is then free to 
associate with an alternative regulatory protein that would allow the secretion of proteins 
through the type III secretion apparatus.  This study provides an alternative mechanism of 
action for the partner switching paradigm.  The partner-switching mechanism of sigma 28 
regulation in Chlamydia should be further examined in an effort to better define its role in 
chlamydial gene regulation. 
 
 Sigma 54 is the second alternative sigma factor encoded by Chlamydia spp. 
genomes.  In many bacteria, including E. coli, sigma 54 coordinates the expression of 
genes related to nitrogen metabolism, most significantly, up-regulation of the glutamine 
synthetase gene glnA during nitrogen starvation.  In that chlamydiae lack glnA, one group 
(Mathews and Timms 2000) conducted in silico studies to find potential sigma 54 
promoters within the genome, taking advantage of the fact that the cognate sigma 54 
promoter sequences are the most highly conserved of all bacterial sigma factor binding 
sequences (Barrios, Valderrama et al. 1999).  Using the FindPatterns program, they were 
able to identify nine promoters that match the sigma 54 consensus sequence (allowing 
two mismatches) that were located within four hundred base pairs upstream of a 
chlamydial open reading frame.  Primer extension analysis was performed to establish the 
chlamydial start sites of these genes.  Only two of the nine predicted promoter regions 
produced a transcript that mapped close to the actual 5’ends: open reading frames 
CT652.1 and CT683.  CT652.1 and CT683 are hypothetical genes with no known 
function, but orthologs with sigma 54-like promoters were also identified in the genomes 
of C. muridarum, and C. pneumoniae.  Also noted was the presence of an upstream 
activator sequence (TGT-N10/11-ACA) to which the NtrC DNA-binding protein is 
critical for activation of expression of sigma 54 genes (Kustu, Santero et al. 1989).  NtrC 
is the DNA binding member of a two-component gene regulatory system that also 
includes the sensor protein, NtrB.  Genes encoding homologs (ctcC and ctcB) are 
encoded by chlamydial genomes, but curiously the NtrC-protein equivalent lacks an 
obvious DNA binding motif, although the protein has been demonstrated to be 
phosphorylated by the NtrB equivalent, CtcB (Koo and Stephens 2003).  Sigma 54 
controlled genes also require binding of integration host factor (IHF) to an upstream 
DNA element to promote a bend in DNA that allows interaction of NtrC with sigma 54 
(Hoover, Santero et al. 1990).  Two putative IHF elements were identified upstream of 
both the CT652.1 and the CT683 promoter regions, and Zhong et al. (2001) demonstrated 
that recombinant chlamydial IHF binds to DNA upstream of the omcAB operon (binding 
upstream of CT652.1 and CT683 has not been tested).  To date, an in vitro transcription 
system using recombinant chlamydial sigma 54 has not been achieved because the 
recombinant is insoluble (T.P. Hatch, personal communication 1997); hence, 
experimental proof that sigma 54 regulates CT652.1, CT683, or any other gene is 
lacking. 
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 In conclusion, the roles for the alternative sigma factors in controlling stage-
specific transcription are unsettled.  At least some late-genes possess sigma 28 promoters, 
but most do not.  Thus, a simple sigma cascade cannot explain temporal gene regulation 
in chlamydiae.  The role of Rsb proteins in temporal regulation, including sigma 28 
activation, remains unclear, and the function of sigma 54 and putative auxillary proteins 
remains a complete mystery.  A better characterization of when sigma and auxillary 
genes and proteins are expressed during the cycle would be useful in support or 
elimination of their roles in temporal expression. 
 
 
DNA Supercoiling 
  
 Supercoiling of DNA can be a method of regulating the expression of genetic 
material in bacteria.  Depending on the superhelicity of the DNA, gene expression can 
either be upregulated or downregulated.  A decrease in the superhelicity of DNA may 
result in either the expression or the repression of a particular gene or subset of genes.  
The cause of this upregulation or downregulation of gene expression is believed to be due 
to the change of promoter activity and efficiency (Dorman 2006).  The change in the 
DNA structure via supercoiling may cause the inability of DNA-binding factors such as 
transcription activators or suppressors to not be able to effectively bind the DNA, thus 
causing the disruption or the enhancement of transcription.  It was discovered that the 
DNA topology downstream of the ilvGMEDA operon of E. coli (which expresses five of 
the six enzymes needed to produce L-isoleucine and L-Valine) regulates the expression 
of the ilvGMEDA operon (Pagel, Winkelman et al. 1992).  Subsequent studies identified 
an element, which they termed the supercoiling-induced DNA duplex destabilized 
structure (SIDD) that when bound by the integration host factor (IHF) protein produced a 
change in the superhelicity of the -10 element of the downstream ilvGMEDA operon, 
resulting in the transcription activation of this operon by increasing the rate of open 
complex formation (Sheridan, Benham et al. 1998).   
 
 Because of studies that have presented DNA topology as a factor in gene 
expression, chlamydial researchers have examined chlamydia for similar genetic 
regulation via DNA topology.  Differences in superhelicity of chlamydial DNA were first 
noticed when the C. trachomatis cryptic plasmid was isolated from EBs and RBs and 
fractionated on a gel.  Different topoisomers of the plasmid were observed in EBs 
compared to RBs (Solbrig, Wong et al. 1990).  A highly supercoiled topoisomer was 
unique to the EB, whereas a less supercoiled topoisomer was unique to the RB.  
Differences between the two plasmid isolates were denoted by both gel migration 
patterns and by appearance using electron microscopy.  The differences in the 
superhelicity of the plasmid lead researchers to hypothesize that the DNA topology may 
play a role in the inert nature of EBs vs. active gene expression in RBs. 
 
 Others addressed the role of DNA topology in regulating gene expression in 
chlamydiae by examining the in vitro activity of five chlamydial promoters (Niehus, 
Cheng et al. 2008).  They examined two genes ompA (major outer membrane protein) and 
pgk (phosphoglycerate kinase), which are expressed during the mid-cycle stage of 
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development, and three genes, omcAB (cysteine-rich proteins), hctB (histone-like 
protein), and ltuB (late transcription unit B), which are expressed during the late stage of 
the cycle for their responsiveness to modifications to the superhelicity of their promoter 
regions.  It was observed that expression of mid-cycle genes ompA and pgk was increased 
by as much as fifty-fold and eight-fold, respectively, with increased negative supercoiling 
of their promoters.  In contrast, the late genes omcAB, hctB, and ltuB all exhibited a 
modest increase in transcription levels when their promoter regions were subjected to an 
increase in negative supercoiling.  The extent of supercoiling of the DNA was examined 
during the developmental cycle by Niehus et al. by isolating the chlamydial plasmid at 
different times post-infection and subjecting the plasmid to gel fractionation.  They found 
that the plasmid was more negatively supercoiled at the mid-cycle stage compared to 
both the early and the late stages of the developmental cycle.  The increase in 
transcription seen in negatively supercoiled DNA, combined with the evidence that 
chlamydial DNA appears to be more negatively supercoiled during the mid-cycle stage of 
infection when gene expression is high, further substantiates the notion that changes in 
DNA topology is a mechanism by which Chlamydia species may regulate gene 
expression.  In a follow-up study, in vitro transcription analysis to monitor the change in 
expression of stage-specific genes of the type III secrection machinery when the degree 
of supercoiling of the template plasmid was altered (Case, Peterson et al. 2010).  They 
observed that the type III secretion genes that transcribed during middle stages of the 
developmental cycle in vivo increased its expression when negative supercoils are 
introduced to DNA, whereas genes that are expressed late in the developmental cycle in 
vivo expressions were insensitive to the induction of negative supercoils, further 
validating the hypothesis that DNA topology has an effect on genetic expression.  It is 
unclear how closely the in vitro transcription system relates to in vivo conditions and 
what in vivo processes might be responsible for changes in supercoiling of the 
chlamydial genome.  
 
 
Small Regulatory RNA 
  
 Another mechanism by which bacteria regulate gene expression is by small 
regulatory RNAs (sRNA).  sRNAs are defined as untranslated RNAs that are less than 
four hundred nucleotides long and regulate both transcription and translation (Wassarman 
and Steitz 1992) by base-pairing with other RNA molecules or by binding proteins.  
Studies in E. coli have revealed the presence of seventeen non-coding RNAs that possess 
a functional role in gene regulation (Gottesman, Storz et al. 2001).  For example, oxyS 
RNA, induced during oxidative stress, represses the translation of the fhlA gene by 
blocking ribosome binding (Altuvia, Zhang et al. 1998).  In contrast, dsrA RNA 
positively regulates the expression of the rpoS gene (Sledjeski, Gupta et al. 1996).   
 
 Initial evidence that chlamydiae may contain non-translated, regulatory RNAs 
came from studies investigating the transcription of the 7.5 kb cryptic plasmid located in 
the C. trachomatis serovar L2 (Fahr, Sriprakash et al. 1992).  Two transcripts of 250 and 
430 bases with a common 5’ end were identified with predicted bacterial major sigma 
factor promoter -10 and -35 elements.  Both transcripts lacked a strong ribosome-binding 
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site, which suggested that these transcripts may not be translated during the 
developmental cycle.  It was also noted that transcripts were located anti-sense to the 3’ 
end of a predicted transcript that encodes for a recombinase-like protein.  Expression of 
the recombinase-like gene could not be detected by Northern blot or primer extension 
analysis but was found by RT-PCR amplification.  It was suggested but not demonstrated 
that the two short anti-sense transcripts abrogated the expression of this gene therefore 
presenting the first indication of the regulation of gene expression via short non-coding 
RNAs in chlamydiae. 
 
 The chlamydial histone-like proteins, HctA and HctB, also known as Hc1 and 
Hct2, are made late in the developmental cycle and bind to chlamydial DNA to induce 
the electron dense nucleoid seen by microscopy in EBs (Costerton, Poffenroth et al. 
1976).   In an attempt to identify the mechanism by which hctA expression is regulated, a 
heterologous system was constructed in E.coli where they screened plasmids containing 
chlamydial gene library in an effort to find genes that would rescue the lethal phenotype 
when hctA is expressed in E. coli (Grieshaber, Grieshaber et al. 2006).  They discovered 
two loci that would rescue E. coli from lethality.  One was the ispE gene that synthesizes 
the metabolite, non-mevalonate methylerythritol 4-phospate (MEP).  The authors 
speculated that this charged metabolite binds to the positively charged histone protein to 
release HctA from genomic DNA.  A fault with this reasoning is that ispE appears to be 
expressed late in the cycle rather than at immediately early times.  The second locus 
contained a small RNA species, designated ihtA, which inhibited the translation of hctA 
RNA; thereby reducing HctA levels thus rescuing the lethal phenotype.  In C. 
trachomatis, the levels of ihtA increases by four hours post-infection and reach peak 
levels at twelve hours post-infection; this correlated with the decreased expression of 
HctA.  The protein levels of HctA begin to increase around twenty-four hours with a 
concomitant drop in ihtA expression thus validating the initial evidence that it is a 
negative regulator of hctA expression.  
 
 A global search for sRNA species in C. trachomatis identified forty non-coding 
RNAs (Abdelrahman, Rose et al. 2011).  Chlamydia has been observed to produce non-
coding RNAs and this group used an Affymetrix microarray containing the C. 
trachomatis serovar D genome in an effort to identify novel non-coding RNAs.  Forty 
non-coding RNAs were identified and a subset of these non-coding RNAs was subjected 
to further analysis; these non-coding RNAs were analyzed based on their expression 
levels at twenty-four hours, forty-eight hours, and their expression during IFN-γ 
persistence.  These non-coding RNAs were seen to have a distinct temporal expression 
pattern and this expression pattern was altered when a persistent infection was induced.  
This study provided evidence for the role of non-coding RNAs regulating genetic 
expression in Chlamydia and sets the framework for future studies regarding non-coding 
RNAs and the roles they play in genetic regulation.   
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DNA-Binding Proteins 
 
 It has long been known that the binding of proteins to DNA can result in the 
upregulation or downregulation of genes.  These proteins work in a myriad of ways.  
They can direct RNA polymerase binding to specific regions of the genome and help aid 
the initiation of transcription.  These proteins can bind to UP elements upstream from the 
promoter, causing a bend in the DNA to increase the rate of transcription.  They can also 
bind the DNA in such a manner that abrogates transcription.  Predicted DNA binding 
proteins are not common in chlamydial genomes, but several have been identified and 
analyzed for their effect on gene expression. 
 
 Ultrastructural studies noted that DNA within the RB form of chlamydiae was in 
a fibrous, loosely organized “reticulate” state, whereas the EB form contained DNA in a 
compacted, condensed nucleoid state (Costerton, Poffenroth et al. 1976).  Investigators 
identified three DNA-binding proteins of 58, 25, and 17 kDa that were specific to EBs 
and suggested they might be responsible for the compaction of DNA EBs (Wagar and 
Stephens 1988).  Genes encoding two predicted highly basic proteins were eventually 
identified (Hackstadt, Baehr et al. 1991; Brickman, Barry et al. 1993).  DNA sequence 
analysis of one of the encoding genes revealed an amino acid composition similar to the 
eukaryotic H1 histone, as well as sharing primary sequence homology to the H1 family of 
histones (Hackstadt, Baehr et al. 1991).  This grouped named the protein Hc1 (HctA), 
which is expressed during the later stages of the developmental cycle.  An antigenically 
related histone analog, termed Hc2 (HctB), was also identified and analyzed (Brickman, 
Barry et al. 1993).  Expression of hctA gene in E. coli resulted in the compaction of its 
chromosome similar to the condensation of the chlamydial chromosomes.  Both of the 
chlamydial histone-like proteins have been observed to restrict gene transcription in 
E.coli.  The late expression of these proteins, along with its ability to bind and condense 
chromatin material, is believed to be responsible for the transcriptional inactivity of EBs. 
 
 In an attempt to identify proteins that were capable of binding the upstream region 
of the cysteine-rich protein operon, omcAB, one lab fractionated RB extracts on a gel, 
eluted proteins from the gel slices, and incubated the eluates with the promoter region of 
the operon (Zhong, Douglas et al. 2001).  Gel mobility analysis revealed a protein 
between 13 and 16 kDa that caused a shift when allowed to bind the omcAB operon.  
Matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass 
spectrometric analysis revealed the presence of a protein with high similarity to the alpha 
and beta subunits of the integration host factor of other bacteria.  Further analysis of this 
protein revealed that it was able to introduce a bend in the CRP operon promoter region 
and a two-fold increase in transcription was observed when measured via in vitro 
transcription.  The IHF protein was produced during the middle and late stages of the 
developmental cycle, which corresponds with an increase in the expression of the CRPs.  
How and if the chlamyidal IHF alters expression of the CRP operon in vivo has not been 
determined.  A unique feature of chlamydiae is that their genomes encode only one of the 
hetero-dimeric IHF proteins seen in other bacteria.  
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 The chlamydial genome also contains a homologue of the heat-shock gene 
repressor called HrcA (heat regulator at CIRCE element) (Schulz and Schumann 1996).  
HrcA binds to the cis-acting DNA element, CIRCE (controlled inverted repeat of 
chaperone expression), which is located upstream of the promoters to the heat shock 
dnaK and groE operons (Tan, Wong et al. 1996).  It was later shown that the association 
of  HrcA to the CIRCE element caused a repression of dnaK promoter activity via in vitro 
transcription analysis (Wilson and Tan 2002).  In another study, investigators observed an 
element upstream of the groES/groEL promoter, but with a sequence that is highly 
divergent from known bacterial CIRCE elements.  In vitro analysis reveal weaker binding 
of HcrA protein to the groES/EL CIRCE element than to the dnaK element and also 
weaker repression of transcription (Wilson and Tan 2004).  It was also noted that HcrA 
protein repressed in vitro expression of the late-stage, non-stress gene hctA when and 
only when the dnaK CIRCE element was placed upstream of the gene. 
 
 Iron is a necessary element for all living organisms.  It is a key cofactor of several 
enzymes that are responsible for the oxidation of many compounds.  Organisms must 
take up this essential element to ensure survival.  Growing chlamydiae in host cells under 
iron-starved conditions results in a decrease in infectivity, a delay in development, 
abnormal morphological forms, and quantitative changes in the expression levels of 
several proteins (Raulston 1997).  The changes seen in protein expression during iron-
deprivation in bacteria are regulated by a family of repressors that are homologous to the 
E. coli ferric uptake regulator (FUR) protein.  A protein with limited sequence homology 
to the FUR-protein was identified in C. trachomatis and named divalent cation-dependent 
regulator A (DcrA) (Wyllie and Raulston 2001).  DcrA was demonstrated to complement 
an E. coli strain that was mutated so that its FUR protein was not expressed.  Follow-up 
studies were performed to try and identify other sequences in the genome that may be 
under the control of the DcrA (Rau, Wyllie et al. 2005).  In this study, the E. coli FUR 
protein was used to scan the chlamydial genome to identify sequences that were capable 
of being bound by the protein using a FUR titration assay (FURTA).  Twenty-eight 
sequences were identified and were tested via electric mobility shift analysis (EMSA) to 
see if they were capable of being bound by the chlamydial DcrA protein.  DcrA protein 
was able to bind to these sequences although further experimentation, such as in vitro 
transcription, need to be conducted in an effort to validate DcrA function. 
 
 It is believed that the genes that are expressed early during the developmental 
cycle are responsible for the conversion of the EB to the RB.  Before the chlamydial 
genomes were sequenced, Wichlan and Hatch attempted to identify genes that are 
preferentially expressed during the early stages by making use of a unique feature of 
chlamydiae: the ability of host-free RBs to incorporate highly radioactive, exogenous 
GTP into the same mRNA that had been initiated and were in the process of elongation 
when the RBs were present in infected host cells (1993).  The radioactive host-free RNA 
was used to probe a genomic library, and a clone was selected on the basis of its reaction 
with a two-hour probe but not a probe generated at 24-hours.  The identified gene 
encoded a hypothetical protein unique to chlamydiae; it was named early upstream open 
reading frame or EUO because of its early expression and its location upstream of gtlX, a 
gene predicted to encode glutamyl-tRNA synthetase.  EUO gene sequences revealed a 
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positive net charge in the N-terminus and the hydrophobic C-terminal tail, suggesting that 
it could possibly be a DNA-binding protein.  Further studies revealed that EUO 
transcripts are detectable as early as one hour post-infection, are more highly expressed 
relative to rpoD and rRNA at one to two hours post-infection, but continue to be 
expressed during the logarithmic phase of growth, whereas expression sharply declines at 
later stages of the developmental cycle (Zhang, Douglas et al. 1998).  The protein was not 
found in infectious EBs, suggesting that it is not stable.  A putative weak helix-turn-helix 
DNA-binding motif was predicted from the EUO gene sequence and to assess the DNA-
binding activity of EUO, reverse gel-mobility shift assays were carried out.  Radiolabeled 
recombinant EUO was allowed to incubate with EcoRI-digested chlamydial DNA and 
resolved on a non-denaturing polyacrylamide-agarose gel.  Recombinant EUO failed to 
enter the gel in the absence of DNA fragments but was able to enter the gel in the 
presence of multiple fragments chlamydial genomic and BlueScript plasmid DNA, 
indicating that it is indeed capable of binding DNA in a non-specific manner.  The EUO 
gene is located in close proximity of the omcAB operon and gel-shift analysis verified 
that EUO was capable binding to the promoter region of this operon, and DNA footprint 
studies showed that EUO preferred sequences of DNA that were highly AT-rich.  
Binding of EUO to oligonucleotide probes confirmed the preference of EUO to bind to 
AT-rich but not GC-rich sequences.  The intriguing possibility that EUO may function to 
repress transcription of late genes was raised; however, in vitro transcription studies 
found that EUO repressed expression of the mid-cycle ompA gene, as well as the omcAB 
operon---likely because of the relatively non-specific binding of EUO to AT-rich 
sequences in vitro. 
 
 A later study performed a genome-wide search in an effort to define sequences of 
DNA in the chlamydial genome to which EUO prefers to bind (Zhang, Howe et al. 2000).  
A technique called SELEX (systematic evolution of ligands by exponentially enrichment) 
was employed.  This method used enzyme-digested chlamydial DNA to construct a 
library of possible EUO binding targets.  The DNA was ligated into pBluescript and 
allowed to incubate with recombinant EUO.  The mixture of recombinant protein and 
vector was allowed to pass through membranous filter, with unbound DNA passing 
through the filter and EUO-bound DNA being retained.  This DNA/protein hybrid was 
removed from the membrane and the DNA portion of this complex was isolated and 
subjected to amplification in E. coli.  This process was repeated through nine rounds. 
Several clones were selected using this method with the most highly enriched clone 
containing sequence within the coding region of the deoxycytidine triphosphate 
deaminase (dcd) gene.  DNase footprint analysis of this selected clone showed that EUO 
was preferentially binding AT-rich sequences.  With the alignment of the selected clones, 
the weak DNA-binding consensus sequence AHGAAAWVTYTWDAY was derived, but 
it required at least two mismatches to identify all the strong binding sequences in the 
clones selected.   Although this study located genomic sequences to which EUO preferred 
to bind in vitro, the sequences themselves provided no insight into the role of EUO in 
vivo.  More global in vitro and in vivo studies are needed to further define the role of 
EUO in chlamydiae.  One curious finding suggested that EUO is a histone H1-specific 
protease (Kaul, Hoang et al. 1997).  
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OBJECTIVE 
 
 The developmental cycle of Chlamydia spp. is governed by a gene regulatory 
system that is not fully understood.  The conversions of the EB to the RB and the RB 
back to the EB have been described ultrastructurally but the molecular events that are 
responsible for these intercoversions have not been fully characterized.  Although the 
lack of a stable genetic transformation system has hampered progress, several 
mechanisms of genetic control have been identified.  The purpose of this study was to 
look at two possible mechanisms of genetic control: sigma factor regulation and EUO 
DNA-binding regulation, and to further characterize their roles in the regulation of 
chlamydial gene expression.  Sigma factor protein expression during the developmental 
cycle will be examined in Chapter 2, in vitro binding of recombinant EUO to genomic 
DNA will be analyzed by ChIP-to-Chip analysis in Chapter 3, and in vivo binding of 
native EUO to DNA will be examined by an immunoprecipitation-cloning strategy in 
Chapter 4. 
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CHAPTER 2.    PROTEIN EXPRESSION LEVELS OF SIGMA 66, SIGMA 54, 
AND SIGMA 28 THROUGHOUT THE DEVELOPMENTAL CYCLE OF 
CHLAMYDIA 
 
 
INTRODUCTION 
 
 Sequencing of the chlamydial genome revealed the presence of three sigma 
factors: sigma 66, the major sigma factor, and two alternative factors, sigma 54, and 
sigma 28.  The discovery of putative alternative sigma factors stimulated the speculation 
that they may play a decisive role in temporal regulation of chlamydial gene expression. 
In 2000, the Hatch lab (Douglas and Hatch 2000) used reverse transcription polymerase 
chain reaction (RT-PCR) to monitor the transcript levels of these sigma factors to assess 
if they are expressed in a cascade-like fashion.  Sigma 66 transcripts were present 
throughout the developmental cycle although transcripts could not be detected in 
elementary bodies.  Sigma 54 and sigma 28 transcripts exhibited similar expression 
profiles whereby their transcript levels were low during the early stages of the 
developmental cycle and expressions peaked during the logarithmic phase of growth.  
These data suggested that the alternative sigma factors of Chlamydia are unlikely to 
function strictly at the promoters of either late or early stage genes.  Various in silico 
studies have predicted which genes may be regulated by which sigma factors, and in vitro 
transcription studies have confirmed these predictions for a handful of genes.  The first in 
vitro study to examine transcription of all late stage genes identified at the time found 
that their transcription is initiated from sigma 66 promoters (Fahr, Douglas et al. 1995).  
However, in vitro studies from the Tan lab have identified several genes, including one of 
the late stage histone-like genes, are initiated from sigma 28 promoters (Yu and Tan 
2003), reintroducing the possibility of alternative sigma factors playing a critical role in 
stage-specific gene expression. 
 
Previous studies have focused on monitoring the transcript levels of the sigma 
factors.  In a study investigating transcription and translation during chlamydial 
persistence, investigators observed an increase in transcript expression of one stage-
specific gene, EUO, without a concomitant increase in protein expression (Ouellette, 
Hatch et al. 2006).  The mechanism responsible for this uncoupling between transcription 
and translation is not known but suggests the presence of sigma transcripts at a given 
stage of the cycle may not correlate with functional proteins.  Therefore, the objective of 
the studies described in this chapter was to monitor sigma factor protein production 
during the cycle.  The working hypothesis is that analysis of sigma protein levels during 
the cycle may identify one of the alternative sigma factors as a potential regulator of 
stage-specific gene expression.  Chlamydia-infected cells were probed with antibodies 
raised against the sigma factor proteins and their expression levels were monitored via 
immunofluorescence assays.  Western blot analysis of extracts of purified reticulate 
bodies (RBs) was used to confirm the immunofluorescence results.  One of the sigma 
factors, sigma 28, was identified as a potential regulator of gene expression in the late-
logarithmic phase of growth. 
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MATERIALS AND METHODS 
 
 
Growth of Chlamydia Trachomatis Serovar L2 
 
L929 mouse fibroblasts were grown with M199 in suspension culture.  4.0 x 108 
cells were infected with C. trachomatis serovar L2. 3.5 x 105 of the infected cells were 
collected and allowed to grow in Leighton tubes containing microscope slides. 
 
  
Antibodies 
 
Rabbit polyclonal antibodies were provided by Annemarie Douglas in the Hatch 
lab.  They were commercially generated from gel-purified recombinant C. trachomatis 
L2 sigma 66, sigma 28, sigma 54 and EUO proteins by Dr. Douglas.  Monoclonal mouse 
anti-sigma 54 was provided by the Guangming Zhong lab, the University of Texas San 
Antonio HSC.  Monoclonal anti-MOMP and polyclonal anti-CRP were provided by 
Harlan Caldwell, Rocky Mountain Laboratories. 
  
 
Isolation of Chlamydiae 
 
Infected L cells in spinner culture were collected and chlamydial RBs and 
elementary bodies (EBs) were harvested at 10, 16, 24, 36, and 48 hours post-infection 
(hpi).  Spinner cultures were spun down at 1,000 rpm for five minutes to collect the 
infected cells. The cell pellet was suspended in 10 mLs of PBS (Phosphate Buffered 
Saline). The infected cells were lysed via bead sonication in a sonic water bath 
(Meddleton Electronics).  The lysed material was allowed to incubate with DNase (2 
mg/mL) for thirty minutes at a temperature of 37° C. This material was spun down at 
10,000 rpm for 20 minutes in a Beckman Coulter centrifuge.  The resulting pellet was 
suspended in 10mLs of PBS and spun down at 1,000 rpm for 5 minutes.  The supernatant 
was then collected and loaded on a Renocal three-step gradient consisting of 30%, 35%, 
and 40% layers.  This gradient was spun down in an ultracentrifuge at 25,000 rpm for 35 
minutes at a temperature of 4° C.  RBs were isolated from the 30%/35% interface and 
EBs were isolated from the 35%/40% interface.  This material was spun down in 
microcentrifuge tubes in an Eppendorf centrifuge at 10,000 rpm for 10 minutes.  The 
supernatant was discarded and the resulting pellet was resuspended in 100 μLs of gel 
digest mix with a final concentration of 5% beta-mercaptoethanol. 
 
 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis and Western Blot 
Analysis 
 
Preparations of extracts from the various time points (10, 16, 24, 36, and 48 hpi) 
were boiled for 5 minutes.  The samples were then loaded and resolved in one dimension 
on a 13% polyacrylamide gel with sodium-dodecyl sulfate buffer. Sample volumes were 
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loaded and adjusted such that the amount of major outer membrane protein (MOMP) at 
each time point was the same.  The samples were electrophoresed for one hour at a 
constant voltage of 200 volts.  The gel was then subjected to western blot analysis.  The 
proteins were transferred to a polyvinylidene fluoride (PVDF) membrane.  The 
membrane blocked with a 10% milk solution and was probed overnight with rabbit 
polyclonal antibodies directed towards sigma 66, sigma 54, sigma 28, EUO, or the 
cysteine-rich protein complex protein, OmcB.  The dilution of all primary antibodies used 
was 1:1,000.  After overnight incubation with primary antibodies, the membranes were 
washed three times with PBST with fifteen minute agitations.  After the washes, the 
membrane was incubated with a 1:20,000 dilution of horse radish peroxidase-conjugated 
donkey IgG in for 4 hours.  After this incubation, the membrane was washed once with 
PBST and three times with PBS with fifteen minute agitations.  Signal was visualized via 
chemiluminescence with the Immun-Star HRP chemiluminescent kit from Bio-Rad.  
Kodak Biofilm was used in development. 
 
 
Immunofluorescence Analysis (IFA) 
 
Chlamydial proteins were visualized within infected L cells via 
immunofluorescence microscopy.  Leighton tubes containing 3.5 x 105 L2-infected cells 
grown on coverslips were fixed with methanol for 48 hours.  After fixation, the cells were 
blocked for 10 minutes with PBS containing bovine serum albumin.  The slides were then 
incubated with antibodies raised against sigma 66, sigma 54, sigma 28, EUO, or CRP for 
1 hour at 37° C.  Slides were washed with PBS and were allowed to incubate with 
donkey anti-rabbit antibody conjugated to an Alexa fluor for 1 hour at 37° C.  This 
process was repeated for the MOMP counter-stain.  The counter stain antibody was 
detected with a goat anti-mouse antibody conjugated to a FITC fluor.  The coverslips 
were examined using an oil-immersion phase lens on an Axiovision confocal microscope. 
 
 
RESULTS 
 
 
Strategy of Analysis 
 
Protein levels were monitored by IFA of infected cells and western blot analysis 
of extracts of purified chlamydiae.  Each method has its strengths and weaknesses.  IFA 
allows examination of individual inclusions, including at early time points.  However, the 
method is semi-quantitative at best and highly subject to observer interpretation.  In my 
studies, I attempted to photograph images at the same intensity as I observed through the 
optical lens.  Another problem is the potential problem of access of the primary antibody 
into late RBs and EBs because of disulfide cross linkage of the outer membrane complex 
(OMC) late in the cycle.  However, this latter problem is mitigated by the speculated 
incomplete cross-linkage in intracellular chlamydiae (Hatch, Allan et al. 1984).  Western 
blot analysis was normalized by loading lanes with a constant amount of the constitutive 
major outer membrane protein (Figure 2-1), and thus is more quantitative than IFA.   
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Figure 2-1. Coomassie stain of reticulate bodies.  
 
Reticulate bodies (RB) harvested from 16, 24, 36, and 48 hours post-infection were lysed 
and loaded on a 13% polyacrylamide gel.  The amount of extract loaded was adjusted so 
that the amount of MOMP at each time was the same, providing a loading control for the 
IFA studies reported in the remaining western blot Chapter 2 figures. 
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However, it is extraordinarily difficult to obtain sufficient amounts of chlamydial extract 
not contaminated with interfering host material at early time points.  In my studies, I 
found 16 hpi to be the earliest time point yielding consistent results. 
 
 
Sigma 66 Is Expressed throughout Developmental Cycle 
 
The protein expression level of sigma 66 was monitored using IFA and western 
blot analysis.  The time points chosen were 10, 16, 24, 36, and 48 hpi, thereby 
encompassing the early (10 hpi), middle (16 and 24 hpi), and late stages (36-48 hpi) of 
the developmental cycle.  Due to difficulties in obtaining sufficient material at early time 
points, the 10 hour time point was omitted in western blot analysis.  Sigma 66 protein 
was detected as early as 10 hpi by IFA (Figure 2-2).  At this time point, chlamydia 
inclusions were very small and completed either no rounds or only a few rounds of 
division.  To determine if the sigma 66 protein was chlamydia-specific and not due to 
background noise, monoclonal antibodies to MOMP were used as a counter-stain.  In 
these experiments, the sigma 66 staining overlapped with the MOMP counter-stain and 
was absent throughout the rest of the field, indicating that the sigma 66 protein was 
confined to the chlamydial inclusion.  Sigma 66 protein was also observed also at the 16 
and 24 hour time points, suggesting that the protein is present throughout the logarithmic 
phase of the chlamydial growth. Sigma 66 staining at the 36 and 48 hour time points 
appeared less intense and was speckled throughout the inclusion, suggesting that the 
expression of sigma 66 may be declining during the time of RB-to-EB conversion. 
 
To confirm the IFA results, western blot analysis was performed (Figure 2-3).   
Similar amounts of sigma 66 protein were detected in the 16, 36, and 48 hour samples, 
suggesting the level of sigma 66 is present in roughly equal amounts throughout the 
logarithmic and late stages of growth.  I attribute the lack of detection of sigma 66 protein 
in the 36 and 48 hour immunofluorescence samples to the partial cross-linking of the 
OMC in late RBs and in EBs, thereby impeding antibodies from entering the chlamydia.  
The surface-exposed MOMP is not subject to a similar restriction.  The slight increase in 
sigma 66 expression at 24 hour sample in the western analysis may be attributed to 
inaccurate loading of material because all proteins examined at this time point exhibited a 
peak in expression (Figure 2-1).  
 
In summary, sigma 66 protein was observed early, during the logarithmic phase of 
growth, and at late times post-infection --- supporting the hypothesis that sigma 66 may 
function in the initiation of stage-specific as well as house-keeping genes in Chlamydia. 
 
 
Sigma 54 Is Expressed throughout the Developmental Cycle of Chlamydia 
 
Sigma 54 protein expression was monitored by IFA throughout the course using 
rabbit polyclonal antibody directed against gel-purified recombinant C. trachomatis L2 
sigma 54.  The protein was observed as early as 10 hpi (Figure 2-4).  At this time point, 
staining was dull and diffuse but present in every inclusion.  Sigma 54 protein increased  
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Figure 2-2. IFA of sigma 66 in C. trachomatis-infected cells. 
 
Infected cells were fixed with MeOH for 48 hours at the times indicated.  The cells were 
reacted with rabbit polyclonal sigma 66 and monoclonal MOMP antibodies.  Hoescht 
was used to stain DNA. 
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Figure 2-3. Detection of sigma 66 protein in reticulate bodies.    
 
Western blot analysis was performed on RBs isolated at 16, 24, 36, and 48 hpi.  Rabbit 
polyclonal serum generated against sigma 66 was used to probe the extracts.  MOMP was 
used as a load control.  Protein standards (not shown) indicated the reactive bands shown 
were of a relative molecular mass of 66 kDa.
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Figure 2-4. IFA of sigma 54 in C. trachomatis-infected cells. 
 
Infected cells were were fixed with MeOH for 48 hours at the times indicated.  The cells 
were reacted with rabbit polyclonal anti-sigma 54 and monoclonal MOMP antibodies.  
Hoescht was used to stain DNA. 
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from the 10 hour to the 16 hour time point.  Curiously, close examination of the 
inclusions at 16 and 24 hpi revealed that the pattern of sigma 54 staining appeared similar 
to the MOMP and associated with the OMC rather than the cytoplasm of RBs, the 
expected location of a sigma factor.  This odd observation will be further investigated 
later in this chapter.  The level of sigma 54 did not noticeably change throughout the 
cycle from 16 to 48 hpi, but remained very high.  To verify these results, sigma 54 was 
monitored by western blot analysis (Figure 2-5).  For reasons that are unclear, detection 
of sigma 54 antigen by western analysis of chlamydial extracts using the polyclonal 
antiserum was inconsistent, often yielding blurred bands and a high background.  Of the 
dozen or more gels run, the one shown in Figure 2-5 was the best.  In the blot shown in 
Figure 2-5, bands were detected at all times, with a sizable increase between 16 and 24 
hpi.  About the same amount of material was detected from 24 to 48 hpi.  In summary, 
the western blot and IFA studies were consistent, with sigma 54 detected at relatively 
early through late times hpi, suggesting that this sigma factor could function at any time 
from 10 to 48 hpi.   
 
 
Sigma 28 Is Expressed during the Logarithmic and Early Late Phases of Growth 
 
Sigma 28 protein levels were monitored from 10 to 48 hpi by IFA (Figure 2-6).  
At 10 hpi, the staining was dull, not clearly present in every inclusion and may represent 
background staining.  At 16 hpi, sigma 28 protein staining was relatively bright and 
completely overlapped with the MOMP counter-stain, indicating its presence in every 
inclusion.  At 24 hpi, the intensity of the sigma 28 stain was similar to the 16 hpi stain but 
it was restricted to the periphery of the inclusion.  Similar to the sigma 66 antibody, the 
possibility of sigma 28 antibody being blocked from entering the elementary bodies due 
to the cross-linkage of its outer membrane cannot be overlooked.  At 36 and 48 hours 
post-infection, the expression of sigma 28 began to decline as evident by the decrease in 
staining intensity and the absence of sigma 28 stain from most inclusions.   
Sigma 28 protein was detected by western analysis in the earliest time point 
examined, 16 hpi (Figure 2-7).  Protein levels increased from the 16 to the 24 hours and 
thereafter declined but did not disappear. In summary, the IFA and western blot studies 
suggest sigma 28 protein level is absent or at very low levels early during the logarithmic 
phases of growth, peaks at about 24 hpi and declines thereafter.  In all the experiments 
described to this point, only RBs were detected at 24 hours, both by IFA and in the 
purification gradients.  The 24 hpi time most likely represents the late log phase of the 
cycle, just before EBs are formed.  Taken altogether, sigma 28 most likely is not present 
in significant amounts at early log phase and late in the cycle.  Thus, if sigma 28 
functions in some way to regulate temporal gene expression, it most likely does so at the 
beginning of RB to EB transition. 
 
 
Polyclonal Sigma 54 Cross-Reacts with an Antigen in the OMC 
 
As described above, the Hatch lab rabbit polyclonal antibody that was generated 
against chlamydial sigma 54 reacts inconsistently on western blots of chlamydial extracts  
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Figure 2-5. Detection of sigma 54 in RBs by western blot analysis.   
 
Western blot analysis was performed on RBs isolated at 16, 24, 36, and 48 hpi.  Rabbit 
polyclonal serum generated against sigma 54 was used to probe the blot.  MOMP was 
used as a load control. Protein standards (not shown) indicated the reactive bands shown 
were of a relative molecular mass of 45 kDa. 
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Figure 2-6. IFA of sigma 28 in C. trachomatis-infected cells. 
 
Infected cells were fixed with MeOH for 48 hours at the times indicated.  The cells were 
reacted with rabbit polyclonal anti-sigma 28 and monoclonal MOMP antibodies.  
Hoescht was used to stain DNA. 
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Figure 2-7. Detection of sigma 28 in RB extracts by western blot.   
 
Western blot analysis was performed on RBs isolated at 16, 24, 36, and 48 hpi.  Rabbit 
polyclonal serum generated against sigma 28 was used to probe the extracts.  MOMP was 
used as a load control.  The reactive band migrated with a relative molecular mass of 28 
kDal. 
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and reacts in IFA with a pattern consistent with reaction with the OMC.  Recombinant 
sigma 54 is highly insoluble, which may be a factor in the peculiar reaction of the 
antibodies.  However, the antibody does react with recombinant sigma 54 by western blot 
and antibody purified from western blots of recombinant protein continues to react with 
the perimeter of RBs (Thomas Hatch, personal communication 2003).  To further explore 
the problem of the cellular location of sigma 54, the Hatch lab recombinant protein was 
sent to the Guangming Zhong lab for generation of a mouse monoclonal antibody.  
However, the recombinant protein failed to generate antibody that reacted with infected 
cells.  Consequently, the Zhong lab generated a soluble recombinant sigma 54 from a 
GST-tagged truncated sigma 54 protein.  This protein was used to boost one time the 
mouse previously inoculated with the Hatch lab recombinant.  The following studies 
were undertaken to compare the reactions of the polyclonal and monoclonal antibodies.  
L cells were infected with C. trachomatis serovar L2 and samples were obtained at 10, 
16, 24, 36, and 48 hpi.  IFA was performed with the sigma 54 rabbit polyclonal and 
mouse monoclonal antibodies (Figure 2-8).  IFA was also performed using the mouse 
monoclonal sigma 54 antibodies, polyclonal EUO, an early stage marker, and CRP, a 
late-stage marker (Figure 2-9).  At the 10 hpi, the inclusions were small, but there was 
complete overlap of the reaction of the two sigma 54 antibodies (Figure 2-8).  Overlap 
was also observed in the 16-hour time point and the intensity of the staining increased 
from the 10-hour sample.  Differences in staining between the two antibodies first 
appeared in the 24-hour time point, when the polyclonal serum continued to stain the 
entire inclusion and the monoclonal antibody began to be more concentrated around the 
periphery of the inclusion.  There were areas within the interior of the inclusion that 
stained brightly with the polyclonal serum but either stained weakly with the monoclonal 
antibody or lacked the monoclonal stain altogether.  This trend continued in the 36 and 48 
hour samples.  Also, the intensity of the monoclonal antibody stain decreased at later 
times.  RBs are located at the periphery of the inclusion, and it is widely believed that 
dividing RBs are attached to the inclusion membrane and that as RBs convert to EBs, 
they become detached and relocate to the interior of the inclusion.  The data shown in 
Figure 2-9, in which the monoclonal sigma 54 reactions are compared to EUO and CRP, 
confirms that the antigen recognized by the monoclonal is present as early as 10 hpi, 
when EUO is also present, and very late in the infection, when CRP is present.  A notable 
point, however, is that at very late times, the sigma 54 antigen is concentrated in RBs still 
attached to the inclusion membrane, whereas the CRP marker is intense throughout the 
inclusion. 
 
It is possible that sigma 54 protein is present in two forms: one form found in the 
interior of RBs, recognized well by the monoclonal antibody and poorly by the 
polyclonal, and a second form in the OMC of RBs and EBs, recognized well by the 
polyclonal but not the monoclonal.  To explore this possibility, IFA was performed on 
purified EBs, which were allowed to adhere to a microscope slide and fixed with 
methanol for 48 hours.  A control experiment was performed using MOMP antibodies to 
confirm that EBs did adhere to the slide and that the small “EB dots” were not specs of 
background (data not shown).  The procedure was repeated using the polyclonal serum 
anti-sigma 54 as the primary stain and the monoclonal antibody as the counter-stain.  The 
polyclonal serum stained the EBs brightly and the monoclonal antibody stain was mostly  
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Figure 2-8. Polyclonal vs monoclonal IFA of sigma 54 in C. trachomatis-infected 
cells. 
 
Infected cells were harvested at the times indicated and were fixed with MeOH for 48 
hours.  The cells were reacted with polyclonal sigma 54 and monoclonal sigma 54 
antibodies.  Hoescht was used to stain DNA. 
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Figure 2-9. IFA of sigma 54 in C. trachomatis-infected cells during the 
developmental cycle using monoclonal antibody. 
 
Infected cells were fixed with MeOH for 48 hours at the times indicated.  The cells were 
reacted with monoclonal sigma 54 antibodies. As a counterstain, either polyclonal EUO 
(early) or polyclonal CRP (mid-cycle and late) antibodies were used.  Hoescht was used 
to stain DNA. 
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absent (Figure 2-10).  Because of the small size of EBs (about 2 microns in diameter), it 
was not possible to resolve MOMP or sigma 54 staining to the OMC.  One interpretation 
of these results is that the polyclonal antibody reacts with an antigen on the surface of 
EBs whereas the monoclonal antibody does not.  Because of the cross-linked nature of 
the OMC in isolated EBs, it was not possible to ascertain whether either antibody reacted 
with an antigen in the cytoplasm of EBs.  Western blot analysis was used to further 
examine the differences in antibody staining between the polyclonal serum and the 
monoclonal antibody.  Initially, reaction to the Hatch lab recombinant His-tagged sigma 
54 was examined by western blot to determine if the polyclonal and monoclonal 
antibodies detected denatured sigma 54.  Both antibodies reacted identically, including 
reaction with a band that migrated around the 50 kDa marker (Figure 2-11).  Other bands, 
also seen on Coomassie stained gels (not shown), most likely degradation products, were 
observed with both the polyclonal serum and the monoclonal antibody.  Next, reaction of 
the two antibody preparations with chlamydial extracts was examined (Figure 2-12).  L 
cells were infected and chlamydiae were harvested at 16, 24, and 36, and 48 hpi.  The 
sample size was adjusted so that reaction with MOMP was constant.  Multiple banding 
was seen in the samples probed with the polyclonal serum, although the major band 
migrated below the 37 kDa marker. The lower bands may be degradation products of the 
larger protein.  The monoclonal antibody preparation reacted with a single band that 
migrated just above the 37 kDa marker.  In that the detection of sigma 54 in chlamydial 
extracts has not been reported in the literature, the relative migration rate of sigma 54 on 
gels is not known, thus it is not possible to conclude with certainty that the major 
polyclonal band or the single monoclonal band is sigma 54.  However, the western 
analysis suggests that the two antibody preparations are not detecting the exact same 
antigen, although they may both be detecting some form of sigma 54 protein.  Because 
the polyclonal serum IFA reaction pattern is similar to that of anti-MOMP (i.e., RBs look 
like “donuts”), the possibility of the polyclonal serum cross-reacting with MOMP was 
addressed.  The variable antigenic regions of the MOMP are located on the surface of the 
OMC of chlamydiae.  OMCs from EBs were prepared to assess if the antigen that is 
recognized by sigma 54 polyclonal serum is in the complex.  This was performed by 
treating EBs with SDS, which solubilizes all proteins not present in the supra-molecular 
disulfide-bonded OMC.  Once these complexes were isolated, they were allowed to 
attach to microscope slides and stained with sigma 54 polyclonal.  Immunofluorescent 
assays revealed that sigma 54 polyclonal intensely stained the OMCs and overlapped the 
reaction with MOMP monoclonal antibody (Figure 2-13).  This suggests that the sigma 
54 polyclonal serum reacts with an antigen in the OMC, either the MOMP antigen or 
some unrelated OMC antigen.  
To further assess the possible cross-reaction between the polyclonal sigma 54 
serum and MOMP, purified EBs were treated with trypsin.  MOMP stain was unaffected 
by trypsin treatment of the EBs (Figure 2-14), but sigma 54 polyclonal serum staining 
was nearly undetectable in the samples that were treated with trypsin. These experiments 
suggest that the sigma 54 polyclonal serum does not cross-react with the MOMP antigen 
and is fully accessible to trypsin in the OMC and, therefore, are not likely to be 
embedded in the outer membrane. 
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Figure 2-10. IFA of sigma 54 in purified C. trachomatis EBs. 
 
EBs were harvested and purified at 48 hpi and fixed with MeOH for 48 hours.  They were 
reacted with polyclonal sigma 54 and monoclonal sigma 54 antibodies.  Hoescht was 
used to stain DNA.   
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Figure 2-11. Western blot analysis of His-tagged sigma 54 protein. 
 
Recombinant His-tagged sigma 54 was detected with (A) monoclonal antibodies and (B) 
polyclonal serum.
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Figure 2-12. Western blot analysis of reticulate bodies using sigma 54 monoclonal 
antibodies and sigma 54 polyclonal serum.   
 
Western blot analysis was performed in duplicate on gradient purified reticulated bodies 
isolated at 16, 24, 36, and 48 hours post-infection.  One blot was probed with monoclonal 
antibodies to sigma 54 and the other blot was probed with polyclonal serum to sigma 54.  
MOMP was used as a load control. 
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Figure 2-13. Immunofluorescence microscopy of C. trachomatis outer membrane 
complexes (OMCs). 
 
SDS-OMCs were generated and fixed for 48 hours and were reacted with polyclonal 
sigma 54 antibodies and monoclonal MOMP antibodies.  Hoescht stain was used as a 
negative control to determine the presence of contaminating EBs.   
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Figure 2-14. Immunofluorescence microscopy of C. trachomatis EBs treated with 
trypsin. 
 
EBs were treated with trypsin and were reacted with polyclonal sigma 54 antibodies and 
monoclonal MOMP antibodies.   
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To confirm this assessment, western blot analysis was performed on purified EBs 
(Figure 2-15). The samples were probed with either the MOMP antibody or the sigma 54 
polyclonal serum.  The MOMP antibody detected a band above 37 kDa (the expected size 
of the MOMP), whereas the polyclonal sigma 54 antibody detected a band below 37 kDa, 
as seen previously in Figure 2-12, confirming that the polyclonal sigma 54 serum does 
not cross-react with MOMP. In summary, the sigma 54 serum detects a trypsin-sensitive 
antigen located in the OMC of EBs and this antigen also appears by IFA of infected cells 
to be present in the OMC of RBs by 16 to 24 hpi. 
 
 
DISCUSSION 
 
Reverse transcription polymerase chain reaction was used to monitor the 
expression of the sigma factors transcripts during the developmental cycle (Douglas and 
Hatch 2000).  It is possible that these transcripts are not translated into protein; hence the 
rationale for examining sigma protein levels during the cycle. 
 
 In immunofluorescence assays, sigma 66 was seen to be expressed at the earliest 
time point (10 hours) examined and continued to be expressed through the later stages of 
the cycle.  Western blot analysis showed sigma 66 being highly expressed at each time 
point examined, although time points before 16 hours could not be probed due to the 
difficulty in obtaining sufficient material to run on a western.  Altogether, the results 
suggest that the sigma 66 protein is highly expressed throughout the developmental cycle.  
Sigma 66 is highly homologous to the major sigma factors sigma 70 of E. coli and sigma 
43 of B. subtilis.  Also, in vitro studies have shown sigma 66 regulating the expression of 
genes expressed throughout the developmental cycle, including housekeeping genes.  
Therefore it is believed to be the major sigma factor of chlamydia.  This study supported 
this hypothesis.  The alternative sigma factor, sigma 28, was nearly absent at both early 
and very late time points when monitored via IFA; western analysis revealed similar 
findings: sigma 28 protein levels being highest during the mid-logarithmic phase with a 
gradual decline in expression at the latter stages of the infection cycle.  In vitro studies 
have identified several genes that appear to be under the control of sigma 28 regulation.  
One of the most characterized of these genes is hctB, the gene responsible for the 
production of one of the histone-like proteins.  This gene is considered a late gene 
because it is not expressed at early time points (0 to 12 hpi), but transcripts can be 
detected as early as 16 hpi (Fahr, Douglas et al. 1995; Belland, Zhong et al. 2003).  It is 
possible that hctB is better considered an “early” late gene, and the synthesis of this 
histone-like protein plays a key role in the triggering of RB to EB conversion.  Following 
this train of thought, sigma 28, via its regulation of hctB, may be “key” to the entry of 
RBs into the late phase of the cycle.   
 
 In preliminary studies not reported here, I (and others in the lab) confirmed by 
Northern blot analysis that sigma 28 is a late phase gene but the transcripts decline 
dramatically at the end of the cycle and are undetectable in EBs.  This is in contrast to 
other late-phase genes, which appear to persist in EBs to the point that they can be 
detected up to 2 hours post infection in EBs in the process of converting to RBs 
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Figure 2-15. Western blot detection of MOMP and sigma 54 in EBs. 
 
EBs were gradient purified and were probed with monoclonal MOMP antibodies or 
polyclonal sigma 54 serum.  
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(Douglas and Hatch 2000; Belland, Zhong et al. 2003; Abdelrahman, Rose et al. 2011).  
These transcripts are not translated, but it is not known why this is so.  In any event, the 
finding that sigma 28 transcription declines very late in the infection is consistent with 
the hypothesis that it plays a role very early in the RB to EB reorganization process rather 
than some terminal event.  The temporal expression of sigma 54 was not completely 
settled by my studies because the rabbit polyclonal and mouse monoclonal sigma 54 
antibodies appeared to identify different antigens.  The polyclonal antibody recognized an 
antigen present in EBs (hence also present at very early time points post-infection) and at 
10 hpi.  Levels of sigma 54 antigen were highest late in the cycle when inclusions 
contained mostly EBs.  Interestingly, the pattern of staining with the polyclonal changed 
from the 10 to the 24 hour samples.  At 10 hpi, the pattern was somewhat punctate and at 
later times the antigen was associated with the OMC.  One interpretation of this result is 
that at very early times (10 hours and earlier), the sigma 54 antigen present in infecting 
EBs undergoes a slow degradation in the cytoplasm and that newly synthesized protein 
during the logarithmic and late phases is associated with the OMC.  The monoclonal 
antibody also detected antigen at 10 hours and later in the cycle but was not present in 
EBs, but the pattern of staining was consistent with a chlamydial cytoplasmic location.  
At very late times, the monoclonal stained primarily residual RBs still attached to the 
inclusion membrane.  Whereas it is not clear what the nature of the polyclonal antigen is, 
the monoclonal most logically does detect cytoplasmic and presumably functional sigma 
54, and that sigma 54 is found only in dividing RBs.  
 
In silico studies predicted several possible targets for sigma 54 binding (Mathews 
and Timms 2000).  Primer extension analysis identified two genes that may be targets for 
sigma 54 on the basis of location of possible bacterial sigma54 promoter sequences 
upstream from the 5’ ends of the transcripts.   Both genes are predicted to encode 
hypothetical proteins not closely related to other known bacterial proteins.  The authors 
suggested that sigma 54 may be a late phage sigma factor on the basis of their RT-PCR 
analysis of sigma 54 RNA and the two target genes expression profiles.  However, their 
data was not consistent with the transcriptome analysis of C. trachomatis (Belland, 
Nelson et al. 2003) and the studies of the Hatch lab (Douglas and Hatch 2000), which 
identified sigma 54 transcripts early in the logarithmic phase of growth.  As stated above, 
my results are more consistent with sigma 54 being a mid-log phase sigma factor. 
 
A significant problem when assessing the temporal function of sigma 54 is the 
insoluble nature of the full-sized recombinant protein, which precludes in vitro translation 
studies.  Consequently, the target(s) and time of function of sigma 54 are not known. 
 
 An interesting observation in this study was the ability of the rabbit polyclonal 
sigma 54 serum to detect an antigen that stains intensely in the OMC of chlamydiae, 
particularly in very late phase inclusions.  Two important questions arise from this 
observation:  First, does the antibody recognize MOMP?  My studies indicate that the 
antigen is not MOMP (Figure 2-14).  Second, does the antibody recognize some form of 
sigma 54 protein or some totally unrelated chlamydial OMC antigen?  Whatever the 
antigen may be, it is unlikely to be the CRP, which is the only OMC antigen present in 
high amounts in the OMC other than the MOMP because CRP is a late protein and the 
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polyclonal antibody reacts well with mid-log phase RBs (Figure 2-9).  Also, whatever the 
antigen is, it presumably was present in the recombinant sigma 54 preparation used to 
generate the antigen.  Was the antigen an E. coli contaminant with the same migration 
rate on the gel as recombinant sigma 54?  This seems unlikely in that no known E. coli 60 
kDa protein (the size of the recombinant) cross-react with any known chlamydial OMC 
proteins.  Was the antibody in the rabbit pre-bleed serum?  No (Thomas Hatch, 
Annemarie Douglas, personal communication 1997).  Is the antigen the same as the 
poorly characterized “Rocky peptidoglycan” antigen (Brown and Rockey 2000).  This is 
possible, but rendered unlikely by the intense staining in EBs that appear to lack 
peptidoglyan and the susceptiblitly of the antigen to trypsin (Figure 2-14).  Altogether, 
the identity of the antigen remains unsettled, but the simplest conclusion is that it 
recognizes some form of sigma 54 in that it was raised against recombinant sigma 54.  If 
the antigen is some form of sigma 54, what is it doing in the OMC?  Does sigma 54 have 
a dual function; an initiator of transcription and a structural role? 
 
 The scope of this study was to monitor the protein expression profiles of the 
sigma factors during the developmental cycle in order to gain insight into their possible 
role in control temporal events in the cycle.  My study succeeded in confirming that 
sigma 66 protein, like its transcripts, is found throughout the cycle.  The study also 
supported the working hypothesis that at least one sigma factor may function in the 
regulation of stage-specific genes.  Specifically, the peak level of sigma 28 protein at the 
early-late phase suggests that it may play a critical role in the transition of RBs to EBs.  
Although the evidence was not entirely clear, my results suggest that the cytoplasmic 
sigma 54 is a mid-log sigma factor and not a late sigma factor, as previously postulated 
(Mathews and Timms 2000).   
 
 Future studies beyond the scope of my studies, which might confirm my 
speculations and more clearly define the function of the alternative sigma factors, will be 
discussed in the final chapter of this dissertation. 
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CHAPTER 3.    IN VITRO IDENTIFICATION OF EUO BINDING SITES USING 
CHROMATIN IMMUNOPRECIPITATION TO MICROARRAY CHIP 
ANALYSIS 
 
 
INTRODUCTION 
 
 All chlamydial species have a unique developmental cycle.  The cycle begins with 
chlamydia in an extracellular, metabolically-inactive form termed the elementary body 
(EB).  Once the EB attaches and is internalized into the target host cell, it begins to 
differentiate into the non-infectious, metabolically-active reticulate body (RB).  After 
several rounds of growth and division the RB switches back to the EB form when it exits 
the cell and begins another round of infection.  The mechanism that is responsible for the 
switch between the EB and RB is unknown.  In an effort to identify genes that may be 
responsible for the initial conversion of the EB to RB, a scheme was developed (Wichlan 
and Hatch 1993) to identify genes that are expressed early in the developmental cycle.  
One of the genes identified was upstream of the gltx gene and was named the early 
expression upstream open reading frame of the gltx gene (euo).  This gene contains a 
helix-turn-helix motif, a characteristic of DNA-binding proteins, and was later seen to be 
capable of binding DNA.  Because of its time of expression and its ability to bind DNA, 
it was postulated to be a possible regulator of genetic expression. 
 
 Attempts were made to identify the DNA-binding sites of EUO and derive a 
consensus binding sequence.  Investigators (Zhang, Howe et al. 2000) used the SELEX 
method (Systematic Evolution of Ligands by Exponentially Enrichment) to address 
which regions of the genome was capable of being bound by EUO.  This protocol 
entailed incubating recombinant EUO with enzyme-digested DNA ligated into a 
Bluescript vector allowing the protein to bind the DNA.  The protein/DNA mixture was 
allowed to pass through a membranous filter.  Unbound DNA was capable of passing 
through the filter whereas the DNA that was bound by the EUO protein passage through 
the filter was abrogated.  The protein-bound DNA was isolated from the filter, cloned, 
and subjected to another round of enrichment.  This procedure was repeated nine times in 
an effort to select out the strongest binding sites for EUO.  Several clones were highly 
selected after the nine rounds of enrichment.  These selected EUO binding sites were 
located within open reading frames (ORFs), which did not agree in principle of EUO 
being a transcriptional regulator.  A weak consensus binding sequence was derived from 
the selected clones, although multiple mismatches had to be allowed to identify the 
clones that were selected.   
 
 This study was another attempt to identify EUO binding sites in vitro.  A 
microarray chip has been developed using the Chlamydia trachomatis serovar D genome.  
The chip contains both the ORFs and the intergenic regions of the genome.  This study 
will use this microarray chip to perform the Chromatin Immunoprecipitation to 
Microarray Chip protocol (ChIP-to-Chip).  In this procedure, chlamydia-infected cells are 
formaldehyde-crosslinked in an effort to preserve the EUO/DNA interaction.  EUO is 
then immunoprecipitated along with its bound DNA.  The DNA is isolated, labeled, and 
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allowed to hybridize with the microarray chip. The major difference between my 
proposed study and that of Zhang et al. (2000) is that I will examine the extent of binding 
of EUO to small fragments (25-mers) in the entire chlamydial genome rather than use a 
selection technique to find the most well-bound fragments.  In short, my approach was 
thought to be more global. 
 
 The working hypothesis of this study is that the microarray readout will reveal 
both strong and weak EUO binding sites within the chlamydial genome that will allow 
the derivation of a consensus and prediction of stage-specific EUO.  For example, strong 
binding to early genes would suggest transcriptional activation, whereas binding to late 
genes would suggest suppression of transcription.  Another goal is to derive a consensus 
sequence for EUO binding and identify the genes that may be regulated by EUO.   
 
 
MATERIALS AND METHODS 
 
 
Growth and Isolation of Chlamydia Trachomatis Serovar D 
 
HeLa cells were grown in 150 cm2 vented cap flasks with DMEM.  After reaching 
75% confluency (20,000 cells) the cells were infected with C. trachomatis serovar D and 
allowed to incubate at 37 degrees under 4% CO2.  At the time of harvest, the infected 
HeLa cells are treated with a 1% solution of trypsin (Gibco) to detach the cells from the 
flask without lysing.  The cells were then collected and were subjected to Renocal 
gradient purification with the similar protocol as outlined in Chapter 2. 
 
 
Preparation of Recombinant His-Tagged EUO 
 
E. coli BL21(DE3)pLysE was transformed with the  pET-28(+) vector that 
contained the entire  EUO gene ligated into the EcoRI site.  E. coli was then grown in 200 
mLs of Luria-broth overnight and spun down 1,000 rpm to form a pellet.  The pellet was 
then dissolved in a 2% SDS solution to release the overexpressed insoluble inclusion 
body.  The His-tagged EUO was then purified by nickel-agarose affinity 
chromatography. 
 
 
Electrophoresis Mobility Shift Assay 
 
The cysteine-rich operon (omcAB) upstream DNA was radioactively labeled with 
fifty μCi 32P-dATP following the instructions of the random primed DNA labeling kit 
from Roche.  After labeling, the radioactive probe was allowed to incubate with either 
recombinant EUO or RB extracts in 20 μL of DNA binding solution (25 mM Tris-HCl, 
70 mM KCl, 20 mM EDTA, 50 μg/ml BSA, 3 mM CaCl2, 1 mM dithiothreitol, 7% 
glycerol) for an incubation period of one hour.  For supershift experiments, anti-EUO 
serum was added at a dilution of 1:100.  Protein-bound DNA was separated from free 
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probe by running the samples on a 5% native polyacrylamide gel.  After electrophoresis 
the gel was dessicated and was exposed to autoradiograph film (Kodak). 
 
 
Immunoprecipitation of EUO from RB and Recombinant EUO/Co-
immunoprecipitated DNA Isolation 
  
Reticulate bodies isolated 18 hours post-infection (hpi) were crosslinked by 
treatment with formaldehyde at a 1% final concentration.  The crosslinked RBs were 
lysed with RIPA buffer (300 mM NaCl, 50 mM Tris, 1% NP-40, 0.5% Deoxycholate, 
0.1% SDS) and allowed to incubate with a 1:100 dilution of anti-EUO serum for one 
hour.  For the recombinant EUO immunoprecipitations, his-tagged EUO and sonicated 
genomic chlamydial DNA were brought up to a 300 μLs volume to ensure mixing. The 
samples were washed three times in RIPA buffer.  If the samples were to be subjected to 
western blot analysis then the immunoprecipitation samples were suspended in 30 μLs of 
digest mix.  If the samples were to be subjected to DNA isolation, they were treated with 
100 μLs of ChIP elution buffer (1% SDS and 20 mM EDTA) and were allowed to 
incubate overnight at 65° C to reverse the formaldehyde crosslinks.  After overnight 
incubation, the DNA from these samples were isolated via phenol/chloroform extraction.  
The DNA was washed twice with 95% ethanol and suspended in 10 μLs of deionized 
water. 
 
 
ChIP-to-Chip Analysis 
 
Isolated EUO co-imunoprecipitated DNA was amplified using the WGA2 whole 
genome amplification kit (Sigma).  After amplification the DNA was labeled with either 
Cy3 or Cy5 and allowed to hybridize to the MPAUT (Multi-Pathogen Array University 
of Tennessee) array.  cDNA was generated from total genomic RNA and was used as a 
positive DNA control. 
 
 
RESULTS 
 
 
Identification of EUO in Chlamydia Trachomatis Serovar D 
 
 The microarray chip used for these experiments was generated using the 
Chlamydia trachomatis serovar D genome; therefore, I had to use Chlamydia trachomatis 
serovar D to perform the ChIP-to-chip procedure.  HeLa cells were infected and 
chlamydia was harvested at 18 hpi.  Eighteen hours post-infection was chosen because 
obtaining sufficient amounts of chlamydia (and EUO) to run on a gel before this time 
point proved difficult.  Also, probing extracts later than eighteen hours resulted in a 
decrease in the amounts of EUO observed compared to the eighteen hour time point (data 
not shown).  These samples were subjected to western blot analysis and probed for EUO.   
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The lab did not possess antibodies to Chlamydia trachomatis serovar D EUO, so I used 
serum that was generated against Chlamydia trachomatis serovar L2 EUO.  BLAST 
searches revealed that the sequences of serovar D EUO and serovar L2 EUO was highly 
homologous (99% identity).  As a control, uninfected HeLa cells were run on the gel in 
an effort to identify any non-specific antibody cross-reaction with the host cell.  I was 
able to detect a single band in the eighteen hpi sample (Figure 3-1).  This band migrated 
below the 20 kDa marker which, is below the expected molecular size of 27 kDa for the 
EUO protein.  We assumed this band was EUO due to the fact that it was the only band 
observed when the sample was probed with the anti-EUO serum.  Also, there was no 
cross-reaction of the anti-EUO serum with the uninfected HeLa cell sample, indicating 
that this reaction was Chlamydia specific.  The difference in the expected migration rate 
of EUO and the observed band was attributed to a difference in migration rates of EUO in 
different species of Chlamydia.  In our lab, when we probe for EUO in C. psittaci 
extracts, EUO appears to migrate at the 25 kDa marker; probing C. trachomatis L2 
extracts, EUO migrates to the 20 kDa marker.  Therefore, we were confident that the 
protein we were detecting in the C. trachomatis serovar D extracts was EUO.   
 
 
Chlamydia Trachomatis Serovar D Binds DNA 
 
 I verified that EUO was present in C. trachomatis serovar D extracts and that I 
was capable of detecting it with the C. trachomatis serovar L2 serum.  The next step was 
to test itsability to bind DNA.  In our lab, we have verified the ability of EUO to bind 
DNA using electrophoresis mobility shift assays (EMSA); thus, I decided to check the 
ability of serovar D to bind DNA via this protocol.  Chlamydiae were grown in HeLa 
cells and harvested at 18 hpi, the time point that EUO appeared to be most abundant in C. 
trachomatis serovar D extracts.  The DNA probe used to test if EUO was capable of 
binding DNA was the upstream region of the CRP promoter region (Figure 3-2).  Past 
experiments have shown that EUO from both C. trachomatis serovar L2 and C. psittaci 
are capable of binding this 267 base pair region of DNA; therefore, I used this region of 
DNA to examine the ability of C. trachomatis serovar D EUO to bind DNA.  The probe 
was generated using forward and reverse primers to PCR-amplify this region of DNA, 
using genomic DNA as a template.  A sample containing the CRP promoter region and 
recombinant His-tagged EUO was used as a control.  In the lane containing His-tagged 
recombinant EUO and DNA there was shift in migration of the DNA probe (Figure 3-3).  
A similar shift was seen in the lane containing 18 hpi chlamydial extracts and the CRP 
probe.  The addition of anti-EUO serum caused a super-shift of the probe, indicating that 
the shift was due to EUO binding the probe and not a non-specific protein binding the 
DNA.  I concluded that EUO from C. trachomatis serovar D was able to bind DNA; or 
more specifically, to bind to the CRP promoter region of DNA. 
 
 
Immunoprecipitation of EUO from C. Trachomatis Serovar D Extracts 
   
 Since I was able to detect EUO in C. trachomatis serovar D extracts and was able 
to demonstrate that EUO was capable of binding DNA, the next step was to 
immunoprecipitate EUO from chlamydial extracts.   Chlamydia-infected HeLa cells were  
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Figure 3-1. Detection of EUO in Chlamydia trachomatis serovar D extracts.   
 
Western blot analysis was performed on uninfected HeLa cells (lane 1) and 18 hpi RBs.  
Antibodies generated against L2 recombinant his-tagged EUO was used to for detection. 
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GAAGTTTGTTTTGTTTGTAGGCAAACTTATCTCTTTGAATCCGAGCTGT
TTATTATTTTATTTTGTTTGCTTTGATTTGCTAATTACCTGTTATTAGA
CGATTTGTTTTAAAAAACAATTGATATAATTTTTATTTTATATGTAATA
TTGTCTATGAGGGCTAGTTTCT 
  
 
Figure 3-2. Cysteine-rich protein (CRP) operon.   
 
The CRP operon encodes two genes: omcA and omcB, which are produced late in the 
developmental cycle.  Transcription of the operon occurs both as a monocistronic 
message, which only codes for omcA, and a bicistronic message, which codes for both the 
omcA and omcB gene. 
 
-35 -10
+1 
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Figure 3-3. Electrophoretic mobility shift assay of the cysteine-rich protein 
operon (-154 to +14).   
 
Both recombinant His-tagged EUO and native EUO from extracts were used to shift gel-
purified crp operon.  Lanes: 1, free probe; 2, probe + his-EUO; 3, probe + his-EUO + 
anti-EUO; 4, probe + 18h serovar D extracts; 5, probe + 18h serovar D extracts + anti-
EUO. 
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harvested and the RBs were isolated and purified at 18 hpi.  RBs were formaldehyde 
cross-linked in an effort to preserve the physiological interactions between EUO and 
DNA.  By doing this, the DNA that is immunoprecipitated with EUO should be the DNA 
that EUO would bind in the context of an infection and not be caused by random binding 
of EUO to non-specific DNA during lysis.  After the cross-linking process, the RBs were 
allowed to incubate with anti-EUO serum and protein A-sepharose beads.  Following 
incubation, the immunoprecipitation samples were washed three times with RIPA buffer 
which contains detergents.  The purpose of these washes was to eliminate any non-
specific binding.  After the washes, the antibody/protein complex was isolated and run on 
a gel and subjected to western blot analysis (Figure 3-4).  A band was present in the 
experimental lane (immunoprecipitation using extract and anti-EUO serum) and was 
absent in the control lane (immunoprecipitation using extract and prebleed serum), 
indicating that this band was specific to the anti-EUO serum.  This band, however, 
migrated just below the 25 kDa marker, which was higher than expected.  When 18 hpi 
chlamydial extracts were probed, a minor band was detected at the 25 kDa marker but a 
major band was detected below the 20 kDa marker.  This lower band was believed to be 
EUO in previous experiments.  Repeated immunoprecipitation experiments resulted in 
the immunoprecipitation of the 25 kDa band and not the 20 kDa band.  I surmised the 20 
kDa band to be a degradation product of EUO that was incapable of being 
immunoprecipitated by the EUO antibodies.  Since I was able to immunoprecipitate full-
length EUO, I proceeded with the attempt to isolate the co-immunoprecipitated DNA.   
 
 
Isolation of Co-Immunoprecipitated DNA from EUO Immunoprecipitations  
 
With the successful immunoprecipitation of EUO protein from Chlamydia 
trachomatis serovar D extracts, the next step was to isolate the co-immunoprecipitated 
DNA.  Once isolated, this DNA would then be labeled and allowed to hybridize to the 
microarray chip to reveal EUO binding sites within the genome.  After EUO was 
immunoprecipitated, the sample was treated with ChIP elution buffer, which functions in 
disrupting the protein A-sepharose beads/antibody/protein/DNA bonds.  The samples 
were then heated at sixty-five degrees overnight to reverse the formaldehyde crosslinks.  
Once these bonds were broken, the samples were treated with a phenol/chloroform 
solution in order to isolate the DNA from the proteins.  Next the isolated DNA was 
loaded and run on a 1% agarose gel.  No DNA was observed (data not shown).  It was 
possible that the amount of the DNA being co-immunoprecipitated with EUO was not 
sufficient to be visualized on an agarose gel.  I attempted to amplify the DNA that co-
immunoprecipitated with EUO in hopes of being able to visualize the DNA on the 
agarose gel.  After the immunoprecipitation of EUO and the isolation of the bound DNA, 
the DNA was subjected to amplification using the Whole Genome Amplification 
(WGA2) kit (Sigma Aldrich).  The samples were then run on a 1% agarose gel.  The 
amplification step did result in visualization of DNA on the gel (data not shown).  It 
seemed that DNA was not being co-immunoprecipitated with the EUO protein.  Another 
possibility relates to the amount of EUO being immunoprecipitated.  Since EUO is a 
minor protein, it can be conceived that the amounts of EUO being immunoprecipitated  
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Figure 3-4. Immunoprecipitation of EUO from Chlamydia trachomatis serovar D 
extracts.   
 
Anti-EUO antibodies were used to immunoprecipitate EUO from 18 hpi extracts.  Lanes: 
1, 18h serovar D extracts: 2, 1st RIPA buffer wash supernatant: 3, 18h serovar D extracts 
+ anti-EUO: 4, 18h serovar D extracts + Prebleed serum. 
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was not sufficient in bringing down enough DNA to efficiently amplify; thereby resulting 
in the ability to visualize DNA on an agarose gel. 
 
 
Immunoprecipitation of Recombinant His-Tagged EUO and Isolation of Co-
Immunoprecipitated DNA 
 
 The ChIP-to-Chip assay is an in vivo protocol that requires the 
immunoprecipitation of a DNA-binding protein from live cells in hopes of co-
immunoprecipitating the DNA that it binds.  I was not able to proceed with the ChIP-to-
Chip experiment under our previous conditions using chlamydial extracts; therefore, I 
decided to switch to an in vitro approach.  I used recombinant EUO and isolated 
chlamydia genomic DNA to perform the immunoprecipitatons.  This would circumvent 
the obstacle of not having enough EUO present to successfully co-immunoprecipitate 
DNA, as seen in the aforementioned in vivo ChIP-to-Chip experiment.   
 
 This in vitro approach required the immunoprecipitation of recombinant His-
tagged EUO.  Attempts to formaldehyde crosslink the recombinant His-tagged EUO and 
the genomic DNA resulted in aggregates of EUO that could not be resolved on a 
polyacrylamide gel (data not shown).  I opted to omit the formaldehyde cross-linking step 
in an effort to successfully immunoprecipitate recombinant His-tagged EUO, although 
the omission of the formaldehyde cross-linking step could result in the disruption of the 
recombinant EUO/DNA interaction which would lead to the inability to co-
immunoprecipitate DNA.  With the omission of the cross-linking step, I was able to 
successfully immunoprecipitate recombinant His-tagged EUO (Figure 3-5).  
Immunoprecipitation of EUO was dependent on anti-EUO serum because using prebleed 
serum did not result in the immunoprecipitation of recombinant EUO.  The next step in 
the ChIP-to-Chip protocol was the isolation of the DNA from the immunoprecipitated 
protein.  I was able to immunoprecipitate recombinant His-tagged EUO with the anti-
EUO serum, but because I omitted the formaldehyde cross-linking step, I wanted to 
verify that during the immunoprecipitation procedure that the recombinant protein/DNA 
interaction was not disrupted.  If I was able to show that DNA was co-
immunoprecipitated with recombinant EUO, I could assume that the interaction between 
the two was not disrupted.   
 
The immunoprecipitation was performed with the same conditions as before.  No 
DNA was observed (Figure 3-6).  I attempted the WGA amplification protocol and DNA 
was visualized in the lane containing DNA isolated from the EUO immunoprecipitation.  
DNA was not observed in the control lane that used prebleed serum to immunoprecipitate 
the recombinant His-tagged EUO.  This would indicate that recombinant EUO/DNA 
interaction was not disrupted with the omission of the cross-linking step and that the 
presence of co-immunoprecipitated DNA was dependent on recombinant EUO being 
immunoprecipitated. 
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Figure 3-5. Immunoprecipitation of recombinant EUO.   
 
Recombinant His-tagged EUO was immunoprecipitated with anti-EUO in RIPA buffer.  
Lane 1, his-tagged EUO + prebleed serum; Lane 2, his-tagged EUO + anti-EUO. 
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Figure 3-6. Isolation and amplification of EUO co-immunoprecipitated DNA.   
 
His-tagged EUO was immunoprecipitated and the EUO-bound DNA was isolated and run 
on a 1% agarose gel.  Panel 1 shows the migration of co-immunoprecipitated DNA: lane 
1, anti-EUO immunoprecipitated His-tagged EUO; lane 2, prebleed immunoprecipitated 
his-tagged EUO.  A DNA ladder is shown at the left side.   Panel 2 shows the migration 
of amplified co-immunoprecipitated DNA; lane 1, anti-EUO immunoprecipitated his-
tagged EUO: lane 2, prebleed immunoprecipitated his-tagged EUO. A DNA ladder is 
shown at the left side. 
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EUO Binds Multiple Regions throughout the Chlamydial Genome 
 
Once the DNA was isolated from the recombinant His-tagged EUO 
immunoprecipitation and amplified, it was then labeled and then allowed to hybridize to 
the MPAUT-1 microarray chip.  The microarray layout is a linear representation of the 
chlamydial genome.  Each probe (dot on the microarray representing a 25-base segment 
of DNA) is arranged in a tip-to-tail fashion with the beginning of the genome starting in 
row one/column one of the layout progressing through the genome with the last 
sequences of the genome being represented at the bottom right corner of the layout.  The 
microarray contains both the intergenic regions and the open reading frames (ORF) of the 
genome.  The intergenic regions have a complimentary dot in the opposite strand, 
whereas the ORFs are represented as a single dot without a complimentary dot in the 
opposite strand.  The cryptic plasmid was represented as a succession of unpaired dots 
located at the end of the microarray chip.  The microarray layout revealed EUO bound to 
multiple regions of the genome (Figure 3-7).  A red dot represented a probe that bound 
strongly with EUO whereas a blue dot denoted a probe that weakly associated with the 
EUO protein.  Both red dots and blue dots were scattered on the microarray layout.  
There were no single regions of the chlamydial genome that seemed to be highly 
concentrated with sequences that were specific for EUO binding.  This experiment was 
performed three times with different preparations of DNA and recombinant His-tagged 
EUO, and similar results were seen in each experiment, suggesting that binding was 
specific rather than due to random background binding. 
 
 
EUO Does Not Preferentially Bind AT-Rich Sequences 
 
Since there was no obvious region of the genome that seemed to be specific for 
EUO binding, I decided to focus my attention on analyzing the sequences of DNA that 
were being bound by EUO.  Zhang et al. demonstrated that EUO preferentially bound 
AT-rich sequences (1998); therefore, I wanted to evaluate if there was a preference for 
AT-content for EUO binding in my studies.  Each probe on the microarray was a 
representation of a 25-base pair sequence; so I inspected the probes that bound EUO with 
high affinity (Table 3-1) and compared their AT-content with the AT-content of the 
probes that weakly associated with EUO (Table 3-2).  The AT-content of the probes with 
the highest hybridization values (fifty-four percent) was lower than the AT-content of the 
probes with the lowest hybridization values (sixty-six percent), which was unexpected 
because previous studies have shown that EUO preferentially binds AT-rich sequences. 
 Analyzing individual probes did not reveal a preference for AT-content in EUO 
binding.   During the immunoprecipitations, EUO was binding fragments of DNA larger 
than 25 base pairs (between 200-700 base pairs as visualized on the gel); therefore, I 
decided to scan the microarray for regions containing consecutive probes with high 
hybridizing values to examine if these larger regions would reveal AT-content being a 
determinant for EUO binding.  Regions containing four or more consecutive probes with 
high hybridizing values were selected and the AT-content was analyzed.  The region with 
the most consecutive probes with the highest hybridization values was the intergenic  
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Figure 3-7. ChIP-to-Chip layout of EUO co-immunoprecipitated DNA hybridized 
to the C. trachomatis serovar D genome.   
 
Degree of binding is indicated from high affinity (red) to low affinity (blue).  Gray 
indicates probes that weakly hybridized with the genomic DNA control. 
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Table 3-1. Probes with the strongest hybridization to EUO co-  
immunoprecipitated DNA. 
 
IGRCT 
Number Sequence 
Hybridization 
Value 
663.56 GCAAACACACCCAGAGACAGTCCAA 29245 
266.03 TCAAAAACAACCAAAAACCAACTAT 16469 
873.22 TTAACCGTAGCCAAGCACACAGAGA 16044 
343.12 ACAATCCCCGGTCTCTTGTGCGTTC 15860 
224.49 AAAATCGAACAGACAACACAATGGC 15603 
744.25 ACAGAGCGGTACAAGGAGATGTCAA 15223 
829.02 CTCCAACCCCAAACCTCACCACTCT 15011 
544.27 ATGCGGCGTATTGTGGATGGATAAG 14653 
343.03 GAACGCACAAGAGACCGGGGATTGT 14564 
080.07 AGAGGGATAACGGCAAGGATTGTTA 14129 
342.10 GACGAAACACCACTAACAAAGATTT 13886 
809.35 GTCGCTGAGCAACGAAACACAAGGA 13856 
740.16 AAAAGGAAGCGAAGATGCAAAAAGA 13615 
150.12 GGTTCAGAAAGTGCAACGTTATGAG 13383 
544.04 ACGAGACCACCATGTTACACCAAAA 13154 
552.17 GCAATCCGAACAAAAGCTCTTGAGA 13035 
873.25 TCTCTGTGTGCTTGGCTACGGTTAA 12693 
450.36 GCGGTGATGAGCAAGGAAATAAGAC 12685 
809.01 TCCTTGTGTTTCGTTGCTCAGCGAC 12497 
150.09 CACCGTGTCTAAAGTATGCGACCAG 12175 
Note: IGRCT = Intergenic region Chlamydia trachomatis. 
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Table 3-2.      Probes with the weakest hybridizations to EUO co- 
immunoprecipitated DNA.    
 
IGRCT  
Number Sequence 
Hybridization 
Value 
446.09 GCCCCCCTCCGGAATTCCGGAGGAG 15.3 
593.1.1 CTGAAGAGAAAAAATTCTCTCTCCC 15.0 
033.06 ATTTAAGAAGCTATCTAATATTAGT 13.2 
629.03 AACCTTTGTCAAACAAAGGTTGATG 13.2 
423.09 CGATAAAAATTTTTATCGATATAGA 13.0 
033.05 ACTAATATTAGATAGCTTCTTAAAT 11.5 
326.2.9 TCTTTGTTAGACCTAAAGGTCTAGT 11.5 
273.13 CAATCATAATCGGGGGAGGGAAAAA 11.4 
643.09 CAGACCCAATATCATTGGGTCCCGG 11.2 
020.03 AAAGAGGTCTTTTAATAAGACCTCT 9.6 
604.08 TCTATTAAAGAATGTTTTAACAGAA 9.6 
498.17 GGTAAGTCTTTTGAAAAGACTCAGC 9.3 
423.02 TCTATATCGATAAAAATTTTTATCG 9.0 
643.63 AGGAAAATGTCAAGGACATTTGCTC 8.9 
619.02 GCTCGCAGGTATATATCTGCGAGCT 7.6 
805.15 TGTTTTTTTCTATCGAAAAAAATCA 7.3 
873.07 TTTTGTTTGATTCAAACAAAAGGAT 7.3 
750.17 AAATAGAGTTTAAGAACTCTAGGGA 7.2 
413.03 AATTAGGCAAGGAATACCTTGCCTA 5.0 
805.01 TGATTTTTTTCGATAGAAAAAAACA 1.5 
Note: IGRCT = Intergenic region Chlamydia trachomatis. 
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region IGRCT 343 (Figure 3-8).  This region was fifty-eight percent AT-rich in content.  
For comparison, I scanned the microarray for a region of consecutive probes with low 
hybridizing values; intergenic region IGRCT 446 (not shown) contained seven 
consecutive probes with low hybridizing values and this region was seventy-three percent 
AT-rich.  These results would suggest that there were factors, other than AT-content, that 
influenced EUO binding to these sites.   
 
Analysis of Selected Intergenic Regions and Open Reading Frames 
  
  As stated above, the intergenic region that exhibited the strongest hybridization 
with the EUO co-immunoprecipitated DNA was intergenic region 343.  This region was 
upstream of a gene that encodes for a protein from the O-sialoglycoprotein endopeptidase 
family.  The expression profile of the O-sialoglycoprotein endopeptidase in chlamydiae 
has yet to be studied; therefore, I could not compare the expression of EUO with the 
expression of this protein.  The intergenic region with the highest hybridization values 
that preceeded a gene with a well-characterized expression profile was the intergenic 
region preceding the late transcription unit B (ltuB) gene.  A previous study has shown 
that ltuB transcripts are first expressed at 24 hpi, coinciding with the decrease in 
expression of the EUO protein; therefore, it is possible that EUO may act as a negative 
regulator of the ltuB gene expression.  Further inspection of intergenic regions also 
revealed a non-late gene possibly being regulated by EUO.  Intergenic region 232, which 
is upstream of the incB gene, also exhibited strong hybridizing with the EUO co-
immunoprecipitated DNA.  The incB gene encodes for a protein that is produced and 
translocated to the inclusion membrane.  The incB protein, in contrast with the late 
expression of the ltuB gene, is produced as early as 2 hpi (Shaw, Dooley et al. 2000).  It 
would seem, according to the intergenic data, that EUO may have a dual role in genetic 
regulation; repressing the expression of late genes and activating the expression of early 
genes.   
 
Analyzing the ORFs proved more difficult than analyzing the intergenic region.  
The intergenic region sequences are represented on the microarray chip arranged in a tip-
to-tail fashion. Therefore, there was complete sequence coverage of the intergenic 
regions and the value of each probe that bound EUO can be determined.  The ORFs are 
represented as a single probe comprised of eleven 25-mers.  The hybridizing values for 
the ORFs are calculated as an average of the eleven 25-mers and the exact value of each 
25-mer within the ORF could not be determined.  Because I could not determine which 
individual 25-mer was responsible with the hybridization with EUO co-
immunoprecipitated DNA, I could not analyze the sequences within the ORFs.  Rather, 
my analysis was restricted to examining the rankings of the ORFs based on their 
hybridizing values.  I grouped both the top twenty ORFs with the highest hybridization 
values (Table 3-3) and the bottom twenty ORFs (Table 3-4) with the lowest hybridization 
values and evaluated them to see if EUO preferred binding to a particular subset of genes.  
The top twenty ORFs contained a varied array of genes with different functions.  The 
gene rsbV2 is a possible transcription regulator.  Glycogen synthase, glgA, produces an 
enzyme that participates in the gluconeogensis.  HctA encodes for a histone-like protein 
that binds DNA and has a role in the condensation of chlamydial chromatin.  Four of the 
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Figure 3-8. Intergenic region 343.   
 
Probe alignment of the intergenic region with the highest hybridization values.  Letters in 
red indicate probes with high hybridization values and letters in black indicate probes 
with low hybridization values. 
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Table 3-3.     Ranking of the ORFs with the highest hybridization values to EUO      
co-immunoprecipitated DNA.   
 
Gene 
Name Gene Description 
Hybridization 
Value 
Time of 
Expression
l t uA  late transcription unit A       5675 16h 
hc t A  histone-like developmental protein       4369 24h 
r l 7  l7/l12 ribosomal protein       4232 3h 
r s 21  S21 ribosomal protein       4179 3h 
y fhC  cytosine deaminase       4086 3h 
r l 13  L13 ribosomal protein       4057 3h 
l t uB  late transcription unit B       4039 24h 
r s bV2  sigma factor regulator       4009 16h 
nus G transcription termination protein       3794 8h 
d s bG possible disulfide bond chaperone       3634 8h 
ye bL  solute-binding protein       3309 8h 
y j fH  rRNA methylase       3279 3h 
oppB1  oligopeptide transport system 
permease protein 
      3212 
3h 
r nc  ribonuclease III       3201 8h 
i nc B  inclusion membrane protein B       3063 3h 
i nc A CHLPS inclusion membrane protein 
A 
      3053 
16h 
e xbB polysaccharide transporter       3000 3h 
g l gA glycogen synthase       2968 16h 
pgs 1  CDP-diacylglycerol-glycerol-3-
phosphate 3-phosphatidyltransferase 
      2913 
3h 
r s 20  s20 ribosomal protein       2912 3h 
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Table 3-4.      Ranking of the ORFs with the lowest hybridization values to EUO co-  
immunoprecipitated DNA.   
 
Gene 
Name Gene Description 
Hybridization
Value 
Time of 
Expression 
fliF flagellar M-ring protein      152 16h 
yojL hypothetical protein      147 8h 
rs14 S14 ribosomal protein      146 16h 
ybcL hypothetical protein      145 24h 
pnp polyribonucleotide nucleotidyltransferase      132 8h 
gspE general secretion pathway protein E      131 3h 
groEL_3 mitochondrial HSP60 chaperonin       121 16h 
yscJ yop translocation J      121 8h 
pmpI putative outer membrane protein I      117 3h 
yprS hypothetical protein      117 8h 
hemZ ferrochelatase      115 8h 
plsX FA/phospholipid synthesis protein      102 8h 
murA UDP-N-acetylglucosamine transferase       91 3h 
lcrD low calcium response locus protein D       91 8h 
maf maf-type protein       90 8h 
rl32 l32 ribosomal protein       79 8h 
gpdA glycerol-3-P dehydrogenase       79 16h 
lipA lipoate synthetase       75 16h 
pyrH UMP kinase       70 8h 
fliI flagellum-specific ATP synthase       57 16h 
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top twenty ORFs were genes that encoded for ribosomal proteins but two ribosomal 
proteins were also present in the bottom twenty ORFs.  There did not appear to be a 
particular subset of genes that was being bound by the EUO protein.  I next examined the 
time of expression of the ORFs that EUO bound, comparing the time of expression of the 
top twenty hybridizing ORFs with the time of expression of the bottom twenty 
hybridizing ORFs.  The time of expression between the two was very similar.  They both 
contained genes that were expressed as early as 3 hpi, as well as genes that were 
expressed as late as 24 hpi.  This observation, similar to the observation of the intergenic 
regions, would suggest that EUO may have a dual role in transcription regulation in 
Chlamydia. 
 
 
DISCUSSION 
 
The binding of recombinant EUO (rEUO) to DNA was first reported in 1998 by 
Zhang et al.  The ability of rEUO to bind DNA was used to select clones that 
preferentially bound to the protein.  Although that study resulted in the identification of 
several preferential binding sites for EUO which led to the derivation of a consensus 
sequence; the consensus was weak and required multiple mismatches to identify other 
selected clones.  It also did not address the in vivo significance of the consensus and the 
binding sites remains obscure, in part because the binding sites were all located within 
ORFs and the ORFs had no obvious connection among them, such as function or time of 
expression.  Therefore, I re-examined the in vitro binding of rEUO to DNA, using a more 
global approach via ChIP-to-Chip analysis to identify short fragments of genomic DNA 
bound to rEUO. 
 
 The microarray approach proved to be much more difficult than anticipated.  C. 
trachomatis serovar D DNA was required and, although this serotype is easier to 
propagate than many others, yields are low; ranging between 10 to 1000 times lower than 
serovar L and C. psittaci.  To remedy this short-coming, I developed a DNA 
amplification procedure based on the relatively new and novel WGA amplification kit. 
 
 Initially, the microarray results were highly promising.  Three totally independent 
experiments yielded an impressive replication of results with nearly all hot-spots and cold 
spots remaining the same, suggesting that binding of rEUO to DNA was “real”, at least at 
the in vitro level.  However, interpretation of the results was confounding.  For one thing, 
hot-spot intergenic microarray probes (25-mers) to which rEUO-precipitated DNA bound 
were no more AT-rich than cold spots, a serious difference from various previous results 
(Zhang, Douglas et al. 1998; Zhang, Howe et al. 2000).  Furthermore, the hot spots failed 
to yield a consensus.  Various other analyses of the intergenic regions also failed to yield 
a meaningful conclusion.  rEUO consistently bound strongly to some ORFs (and weakly 
to others), but these results also defied interpretation.  No correlation could be made 
among the ORFs, either function or time of expression.  Another discouraging result was 
the failure to find an overlap among the Zhang et al. (1998) sequences and my results.   
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The only conclusions I draw from my results are (1) rEUO appears to consistently 
bind to some genomic DNA fragments in vitro better than others; (2) rEUO binds to 
many sequences in vitro; (3) strong binding in vitro is not restricted to intergenic regions; 
(4) there is no evidence for rEUO preference for AT-rich sequence, despite multiple 
previous contrary findings; (5) binding to a consensus sequence was not evident; (6) the 
significance of my results, albeit reproducible, remains obscure.  In short, the working 
hypothesis that this study would reveal specific binding sites that might allow the 
prediction of EUO function and derivation of a consensus binding site was not supported. 
 
 It is possible that in vitro binding of rEUO to DNA is totally irrelevant to in vivo 
events.  This would be usual in that most, if not all other known bacterial DNA binding 
factors bind well, and specifically, in vitro to DNA elements identified by in vivo 
approaches such as analysis of mutants.  It is possible that EUO requires a cofactor 
(protein or ion) for tight specific binding or that the conformation of native DNA in RBs 
engenders more specific binding, which would explain the relatively non-specific binding 
of rEUO to DNA in vitro.  With this in mind, I undertook the in vivo studies described in 
the next chapter. 
 
 An interesting side observation made in the course of my studies was the size 
discrepancy between native EUO detected by western blot in RB extracts of C. 
trachcomatis serovar D (smaller size) and EUO detected by western blot in EUO 
immunoprecipitated from RB extracts (larger size).  The smaller fragment may be a 
degradation product of the larger one.  Presumably the larger fragment is a minor 
component that was concentrated by the precipitation procedure whereas the dominant 
smaller fragment was not precipitable.  Whether or not both fragments bind to DNA is 
not known, but failure of the small fragment to bind may be part of the regulation of EUO 
function. 
 
  
 
 
70 
 
CHAPTER 4.    IN VIVO IDENTIFICATION OF EUO BINDING SITES USING 
CHROMATIN IMMUNOPRECIPITATION AND CLONING ANALYSIS 
 
  
     INTRODUCTION 
 
 EUO is produced early in the developmental cycle of Chlamydia.  The role of 
EUO during the developmental cycle is not known although it is believed to be a possible 
transcriptional regulator due to its time of expression and its DNA-binding capabilities. 
The expression of the euo gene is one of the most highly expressed, if not the most highly 
expressed gene, within the first few hours of infection (Wichlan and Hatch 1993).  
However, protein levels peak during the logarithmic stage of growth when reticulate 
body (RB) forms are rapidly replicating.  EUO begins to decrease in expression early in 
the late stage of the cycle, at the time of RB/EB transition.  Ouellette et al. (2006) also 
demonstrated that EUO transcripts are upregulated during IFN-γ mediated persistence.  
EUO has been shown to bind multiple regions throughout the genome (Zhang et al., 2000 
and Chapter 3), but attempts to identify specific binding sites have been met with limited 
success.  The SELEX method performed by Zhang et al. (2000) and the ChIP-to-Chip 
method performed in Chapter 3 were both in vitro methods; consequently, both 
procedures neglected auxiliary factors, such as accessory proteins or DNA structure that 
may influence EUO’s binding specificity. 
 
 In this chapter, I describe the development of a ChIP-Cloning protocol for 
identifying genomic fragments bound to native EUO in intact RBs isolated at 16 hours 
post-infection (hpi) and in infected cell extracts at 4 hpi.  In an attempt to ensure the 
EUO-DNA interactions were not disrupted during manipulations, the RBs and the 
extracts were treated with formaldehyde to cross-link EUO protein to DNA.  The 
immunoprecipitated DNA was cloned and sequenced and BLAST searches were then 
performed to identify EUO-bound genomic fragments.  The working hypothesis is similar 
to that in Chapter 3; in vivo analysis of DNA fragments bound by native EUO will 
identify strong and weak binding sites that will lead to a prediction of EUO function.   
 
The genes and fragments identified in this study were randomly distributed 
throughout the genome and did not fall into any stage-specific or functional category.  
They also did not overlap with the genes identified in the in vitro ChIP-to-Chip assay 
from Chapter 3, suggesting that sequence alone is not the only determinate in EUO 
binding and that other factors contribute in EUO binding specificity.  Further studies are 
necessary to elucidate the function of EUO.  However, my studies in Chapter 3 and this 
chapter suggest that EUO binding does not strictly regulate early gene expression but 
rather may facilitate, in some unknown fashion, transcription in general during the early 
and logarithmic phases of growth. 
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MATERIALS AND METHODS 
 
 
Growth and Isolation of Chlamydia Psittaci 
 
L929 mouse fibroblasts were grown in spinner culture with Medium 199.  Two 
hundred thousand cells were infected with C. psittaci and allowed to incubate at 37 
degrees.  Before inoculation the cells were incubated at 4 degrees for 2 hours.  Once 
inoculated the cells were shifted to 37 degrees to synchronize the infection.  At the time 
of harvest, the infected cells were spun down to a pellet and lysed via bead sonication. 
The reticulate bodies were isolated by gradient purification as outlined in Chapter 2.   
 
 
Immunoprecipitation of EUO from Infected Cells 
 
C. psittaci infected cells were spun down at 1,000 rpm for 5 minutes at 4 degrees 
Celsius.  Resuspended the pellet with 5 mLs of cold phosphate buffered saline (PBS).  
Sonicated the solution with a probe-tip sonicator with 30 second bursts and 30 seconds on 
rest on ice.  Repeated this step 10 times.  Spun down this solution at 1,000 rpm for 5 
minutes.  Cross-linked the supernatant with formaldehyde (1% final concentration) for 20 
minutes.  Incubated the material with glycine (0.125 M final concentration) to stop the 
cross-linking.  Spun down material to a pellet at 10,000 rpm for 10 minutes.  
Immunoprecipitated EUO from cross-linked, infected cell pellets with the protocol 
outlined in Chapter 3. 
 
 
Southern Blot Analysis 
 
Genomic DNA was isolated from gradient-purified elementary bodies using the 
MasterPure DNA purification kit (Epicentre).  The DNA was digested with BamHI, 
EcoRI, or XbaI restriction enzymes and the digests were electrophoresed in separate 
lanes on a 1% agarose gel.  Radioactive probes were generated by end-labeling EUO co-
immunoprecipitated DNA with 32P.  Transfer of digested DNA and hybridization of the 
probes to DNA was performed as described by Southern (1975). 
 
 
ChIP-Cloning 
 
A total of two hundred thousand L929 cells were infected with C. psittaci.  At 16 
hours post-infection, reticulate bodies were isolated via gradient purification.  The 
reticulate bodies were formaldehyde cross-linked. EUO was immunoprecipitated and 
DNA was isolated/amplified following the protocol in Chapter 3.  The DNA was ligated 
into the pCR2.1 vector and was transformed into TOP10 cells using the TOPO TA 
cloning kit (Invitrogen).  The clones were then sequenced. 
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[35S]-Labeling of Chlamydial Extracts 
 
L929 cells (106) were infected with C. psittaci.  After 15 hours post-infection, the 
infected cells were spun down at 1,000 rpm for 5 minutes.  The pellet was resuspended in 
PBS containing 100 μg  of cycloheximide per mL.  This suspension was then incubated 
for 1 hour with 50 μCi of [35S] methionine at 37 degrees Celsius.  This material was spun 
down at 10,000 rpm for 20 minutes.  The resulting pellet was resuspended in PBS and 
subjected to Renocal gradient purification of the reticulate bodies. 
 
 
Glutathione-S Tagged EUO Pulldown 
 
Recombinant GST-EUO was grown in E. coli and isolated using the GST 
purification kit (Sigma).  Once isolated purified GST-EUO was prebound to glutathione 
beads and incubated 35S-labeled chlamydial extracts.  The beads were washed three times 
and the GST-EUO was eluted from the glutathione beads.  The eluate was 
electrophoresed on a 13% polyacrylamide gel.  The gel was dried and interacting proteins 
were visualized via autoradiography.   
 
 
RESULTS 
 
 
Identification of EUO from Chlamydia Psittaci Extracts 
 
 The first step in ChIP-cloning was the immunoprecipitation of the EUO protein 
from extracts.  L cells were infected with C. psittaci and reticulate bodies (RBs) were 
harvested at different times post-infection.  Samples from 10, 16, and 24 hours post-
infection (hpi) were isolated and were subjected to western blot analysis. These time 
points represent late-early, mid-cycle, and mid-late stages of the infection.  Due to the 
difficulty in obtaining sufficient gradient-purified material at immediately early time 
points in the cycle (0 to 4 hpi) we were restricted to using 10 hpi as the early time point.  
A single band was observed to migrate above the 25 kDa marker, which is the expected 
molecular size of EUO, in each sample at each time point (Figure 4-1).  This band was 
absent when uninfected cells were probed (data not shown).  EUO expression was 
observed to peak at the 16-hour time point. 
 
 
Immunoprecipitation of EUO from Chlamydia Psittaci Extracts 
 
 I chose the 16-hour time point to immunoprecipitate EUO because of its relative 
abundance at this time point.  To ensure that the EUO/DNA interaction was not disrupted 
during the immunoprecipitation of EUO, isolated RBs were formaldehyde cross-linked.  
RBs were purified via Renocal gradient purification and were treated with formaldehyde 
to crosslink DNA-binding proteins to DNA.  Anti-EUO antibodies were used to 
immunoprecipitate EUO from this cross-linked material, which was subjected to western  
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Figure 4-1. Detection of EUO in Chlamydia psittaci extracts.   
 
RBs from 10, 16, and 24 hpi were harvested and subjected to western blot analysis. The 
blot was probed with antibodies to EUO. 
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blot analysis.  A band corresponding with the predicted molecular size of EUO was 
detected; this band was not present in the sample where prebleed serum was used (Figure 
4-2).  An interesting observation was the presence of a band around the 50 kDa marker in 
the RB extract before immunoprecipitation.  It is possible that through the formaldehyde 
cross-linking of the RBs that EUO could have been cross-linked to another protein of 
similar molecular size, but more likely represents a dimer of EUO.  The next step in the 
ChIP-cloning procedure was the isolation of DNA cross-linked to the 
immunoprecipitated DNA.  After heating at 65°C to break the cross-links, DNA was 
isolated and run on a 1% agarose gel, but no DNA was visualized (data not shown).  
Because the amount of DNA may have been insufficient to visualize, the Whole Genome 
Amplification kit was used to amplify the DNA and it was then visualized on the gel 
(Figure 4-3).  I failed to detect DNA in the control sample (extract and prebleed) after 
amplification; therefore, the presence of DNA was dependent on the immunoprecipitation 
of the EUO protein.  Once isolated, the DNA was radioactively labeled and was used to 
probe BamHI, EcoRI, and XbaI digested genomic chlamydial DNA from gradient 
purified EBs on a Southern blot (Figure 4-4).  As a control, DNA from uninfected host 
cells was isolated and digested with BamHI.  The results indicated that the 
immunoprecipitated DNA was of chlamydial origin and not significantly contaminated 
with host DNA.   
 
 
ChIP-Cloning Identifies Several In Vivo Targets of EUO 
 
 Due to the lack of a microarray containing sequences from the C. psittaci genome, 
it was necessary to clone and sequence the EUO co-immunoprecipitated DNA for 
identification.  The amplified, immunoprecipitated DNA was ligated into the pCR2.1 
vector and transformed into TOP10 cells.  These cells were grown and cells containing 
insert was selected via blue-white screening.  To verify these clones contained insert 
sequence, these clones were lysed and the insert sequences were PCR amplified.  Once 
amplified, the PCR products were analyzed on a 1% agarose gel (data not shown).  Insert 
sequences ranged between 100-700 base pairs in size.  The inserts were ethanol 
precipitated and sequenced.  The presence of flanking linker sequences that were attached 
to the DNA during the amplification step caused a significant decrease in the sequencing 
efficiency.  Nonetheless, thirty clones were sequenced.  Once sequenced, the co-
immunoprecipitated DNA was used in BLAST searches to identify where in the genome 
EUO was binding and a list of the genes identified was compiled (Table 4-1).  Five genes 
were membrane proteins, four genes encoded for putative export proteins, and eight 
genes encoded for hypothetical proteins of unknown function, indicating that EUO 
binding was not specific for a particular family of genes.  Also, the identified genes were 
scattered throughout the genome, indicating that EUO binding was not restricted to a 
particular region. 
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Figure 4-2. Immunoprecipitation of EUO from formaldehyde cross-linked 
Chlamydia psittaci RBs.   
 
Sixteen hpi RBs were cross-linked and EUO was immunoprecipitated.  Extracts were 
immunoprecipitated with prebleed serum as a control.  Formaldehyde is denoted as 
HCHO. 
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Figure 4-3. Amplification of EUO co-immunoprecipitated DNA.   
 
DNA was isolated from EUO immunoprecipitations.  Once isolated, DNA was amplified 
and run on a 1% agarose gel.  DNA isolated from prebleed immunoprecipitations was 
amplified and used as a control.  Base pair markers are indicated. 
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Figure 4-4. Southern blot analysis of EUO co-immunoprecipitated DNA.   
 
Genomic DNA was isolated from EBs, digested with the restriction enzymes BamHI, 
EcoRI, or XbaI, and run on a 1% agarose gel to prepared a Southern blot.  EUO co-
immunoprecipitated DNA from 16 hpi RBs was radioactively labeled and allowed to 
hybridize to the blot.  As a control, host cell DNA was digested with EcoRI and ran in the 
far right lane.  No hybridization was seen when host cell DNA was probed with the 
labeled DNA (not shown). 
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Table 4-1.      List of genes identified with BLAST search of EUO co-     
immunoprecipitated DNA. 
 
Clone Number Gene Name 
1 Putative inner membrane protein 
2 Putative general secretion protein 
3 Putative exported protein                  
4 Conserved hypothetical protein        
5  Conserved hypothetical protein        
6 Putative ClpB  ATPase stress related protein   
7 Putative type III export protein          
8 DNA mismatch protein (MutL)               
9 30s ribosomal protein s7 
10 Putative transport-related membrane protein    
11  Putative regulatory protein (V1)      
12 Putative serine/threonine  protein kinase   
13 Putative inner membrane protein    
14 Conserved hypothetical serine-rich protein   
15 Putative exported protein               
16 Putative thiol:disulfide exchange protein   
17 Putative hydrolase 
18 Conserved hypothetical protein 
19 Conserved hypothetical protein 
20 Conserved hypothetical protein 
21 Uncharacterized P-loop hydrolase 
22 YjgP-YjgQ family protein          
23 Conserved hypothetical protein 
24 Acetyl-CoA carboxylase 
25 YjgP-YjgQ family protein 
26 Putative hydroxyethylthiazole kinase 
27 Putative inner membrane protein 
28 Conserved membrane protein 
29 Putative division protein A (gidA) 
30 Conserved hypothetical protein 
 
 
 
 
 
 
 
 
79 
 
Immunoprecipitation of EUO from Infected Cells 
 
 In the studies just described, it is possible that the EUO/DNA interactions could 
have been disrupted during RB purification, before the cross-linking of the RBs.  Another 
concern is the time point in which the EUO/DNA complexes were isolated.  EUO was 
isolated at 16 hpi, the time where EUO expression peaks in order to obtain sufficient 
material for analysis.  Because EUO is expressed very early it may bind more specifically 
at immediately early times or at least bind to different sequences of DNA than at 16 hpi.  
In an attempt to address these concerns, EUO immunoprecipitations from formaldehyde- 
treated extracts of cells at early time points in the developmental cycle the cycle were 
examined.  (Attempts at immunoprecipitating EUO from intact cross-linked infected host 
cells were unsuccessful; not shown.)  We attempted to immunoprecipitate EUO at 2 hpi.  
EUO was not detected in the immunoprecipitation from extracts prepared at 2 hpi (Figure 
4-5) but was detected in infected cell extract prepared at 3 and 4h hpi (Figure 4-6 and 
Figure 4-7).  EUO was not detected when the material was immunoprecipitated with 
prebleed serum, indicating that the immunoprecipitation of EUO from the cross-linked 
infected cells was dependent on the presence of EUO serum. 
 
 
Isolation and Sequencing of EUO Co-Immunoprecipitated DNA from Infected Cells 
 
DNA was isolated from 3 and 4 hpi immunoprecipiates, but was detected on 
agarose gels only in the 4-hours sample (Figure 4-8).  This DNA was cloned and 
sequenced, but sequencing revealed only DNA of host origin.  The presence of DNA was 
dependent on the immunoprecipitation of EUO; therefore, it would appear that EUO 
during the lysis of the infected cells was being released from reticulate bodies where it 
would bind host DNA.  The ability of EUO to bind DNA other than that from chlamydia 
was previously demonstrated in the first study identifying DNA (Wichlan and Hatch 
1993) and the results here further confirm that EUO binding is relatively non-specific. 
 
 
DNase Contains Proteolytic Activity 
 
An attempt was made to eliminate host DNA in infected cell extracts by treating 
the extracts with DNase before the addition of formaldehyde, but the addition of DNase 
resulted in the inability to immunoprecipitate EUO (data not shown).  To confirm that 
DNase treatment was responsible for the inability to immunoprecipitate EUO, an 
experiment was performed in which a 4 hpi extract was divided in two equal parts, only 
one of which was treated with DNase.  Both samples were formaldehyde cross-linked and 
EUO was subjected to immunoprecipitation.  EUO was only detected in the sample that 
was not treated with DNase (Figure 4-9).  The effect of DNase treatment on the capacity 
to detect EUO in 4-hour infected cells extracts directly (without immunoprecipitation) 
was investigated (Figure 4-10).  EUO was not detected in the sample that was DNase-
treated, suggesting the possibility that the DNase was contaminated with proteolytic 
enzymes.  One interesting observation was the presence of bands at the 50 kDa, 75 kDa, 
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Figure 4-5. Immunoprecipitation of EUO from cross-linked infected cells at 2 hpi.   
 
Cells were infected with C. psittaci and at two hpi the cells were collected and subjected 
to EUO immunoprecipitation.  Immunoprecipitation with prebleed serum was used as a 
negative control. 
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Figure 4-6. Immunoprecipitation of EUO from cross-linked infected cells at 3 hpi.   
 
Cells were infected with C. psittaci and at three hpi the cells were collected and subjected 
to EUO immunoprecipitation.  Immunoprecipitation with prebleed serum was used as a 
negative control. 
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Figure 4-7. Immunoprecipitation of EUO from cross-linked infected cells at 4 hpi.   
 
Cells were infected with C. psittaci and at four hpi the cells were collected and subjected 
to EUO immunoprecipitation.  Prebleed immunoprecipitation was used as a negative 
control. 
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Figure 4-8. Amplification of EUO co-immunoprecipitated DNA.   
 
EUO was immunoprecipitated from formaldehyde cross-linked cells at 4 hpi.  The co-
immunoprecipitating DNA was isolated and amplified (Lane 1).  DNA isolated from 
prebleed immunoprecipitations (Lane 2) of the infected cells was used as a negative 
control.  Markers denote size in base pairs. 
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Figure 4-9. Effect of DNase treatment on EUO immunoprecipitation.   
 
Four-hour infected cells were lysed and extracts were formaldehyde cross-linked and 
divided into two equal parts and incubated with or without DNase.   EUO was 
immunoprecipitated and western blot analysis was performed to detect EUO.  Lane 1, -
DNase; Lane 2, +DNase. 
 
 
 
 
 
 
 
 
 
 
 
 
85 
 
 
 
 
Figure 4-10. Effect of DNase treatment of infected cell extracts on EUO.   
 
Four-hour infected cells were isolated and divided in two equal samples.  One sample did 
not receive DNase treatment (Lane 1) and the other sample was treated with DNase (Lane 
2).  Both samples were treated with formaldehyde before electrophoresis.  The samples 
were subjected to western blot analysis and were probed with EUO antibodies. 
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and 100 kDa in the sample that was not treated with DNase.  Because the samples were 
cross-linked, these bands likely represent multimers of EUO or other proteins cross-
linked to EUO.  Next, I examined if the effect seen with DNase treatment was specific for 
EUO, a minor protein, or if other proteins were affected.  Sixteen-hour purified RBs were 
treated with or without DNase.  Coomassie-stained blots were used to identify differences 
in banding patterns, and western blots of the samples were also probed with antibodies to 
heat shock protein 60 (HSP-60).  Treatment with DNase resulted in the disappearance of 
multiple bands on Coomassie blot including the 37-40 kDa MOMP band (Figure 4-11A) 
and the HSP-60 protein was partially degraded in the DNase-treated sample (Figure 
4-11B).  Similar results were obtained with DNase obtained from other labs, including 
molecular biology grade DNase.  It was concluded that DNase could not be used to 
eliminate host DNA because of contaminating proteolytic activity.  Consequently, further 
experimentation on EUO-bound DNA at very early time points were not attempted.  
DNase treatment of lysates of infected cells is routinely performed prior to purification of 
EBs and RBs on Renocal gradients.  It is curious that deleterious effects of the proteolytic 
activity have never been noticed. 
 
 
Binding of Proteins to EUO Was Not Detected via Co-Immunoprecipitations and 
GST-EUO Pulldowns 
 
 It has been established that EUO is capable of binding DNA but the possibility of 
EUO binding other proteins needed to be investigated.  The presence of the two bands 
seen with the detection of cross-linked infected cells in Figure 4-10 lends credence to the 
possibility that EUO may bind other proteins.  To address this possibility, GST-EUO 
pulldowns of extracts of RBs that were labeled with [35S]methionine/cysteine and EUO 
immunoprecipitations from the radiolabeled extracts were performed.  Although several 
bands were observed in both GST-EUO pulldown (Figure 4-12) and the 
immunoprecipitation (Figure 4-13), these same bands were also noted in with about the 
same intensity in control samples (beads without GST-EUO and immunoprecipitation 
with pre-bleed serum).  I conclude that EUO does not bind other proteins in 16-hpi RBs 
that can be detected within the limits of these experiments.  It is particularly noteworthy 
that radiolabeled EUO was detected in the immunoprecipitate.  If an RB protein were 
bound to EUO in a one-to-one ratio, it should have been detected. 
 
 
 DISCUSSION 
 
Previous studies (Wichlan and Hatch 1993; Zhang, Howe et al. 2000) and those 
reported in Chapter 3 all demonstrated that recombinant EUO (rEUO) does not bind to 
DNA randomly but that binding in vitro is relatively non-specific.  The study reported in 
this chapter was undertaken to identify strong and weak sites to which native EUO binds 
to DNA in vivo, with the hope that a more specific pattern of binding could be identified.  
The study suffered from several limitations.  Most importantly, analysis is ideally carried 
out by formaldehyde-fixation of whole cells under specific conditions (for example, in 
the presence of factor X or at time period Y).  In the case of chlamydiae, intact infected 
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Figure 4-11. Effect of DNase on chlamydial extracts and HSP-60 detection.   
 
Sixteen-hour, gradient-purified RBs were isolated and were incubated in the absence 
(Lane 1) or the presence of DNase (Lane 2).  The samples were separated on 13% 
polyacrylamide gels and Coomassie stained (Panel A) or subjected to western blot 
analysis to detect HSP60 (Panel B). 
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Figure 4-12. GST-EUO pulldown from extracts of [35S]-labelled RBs.   
 
Radioactively labeled 16-hpi RBs were lysed, GST-EUO was pulled down from the 
lysate, and the material in the pulldown was analyzed by SDS-PAGE autoradiopraphy.  
Lane 1, 16-h RB extract; lane 2, Pulldown by GST-EUO-glutathione beads; lane 3, 
Pulldown by glutathione beads in the absence of GST-EUO. 
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Figure 4-13. EUO immunoprecipitation from extracts of [35S]-labelled RBs.   
 
Radioactively labeled 16-hpi RBs were lysed, EUO was immunoprecipitated, and the 
material was analyzed by SDS-PAGE autoradiopraphy.  Lane 1, extract alone; lane 2, 
precipitate using prebleed serum; lane 3, precipitate using anti-EUO serum. 
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cells would be fixed at early, middle, and late time points.  Unfortunately, I was not able 
to immunoprecipitate EUO from whole fixed infected cells.  Thus, I settled on analysis of 
fixed purified RBs.  Previous studies in the Hatch lab (Crenshaw, Fahr et al. 1990) 
demonstrated that host-free RBs transcribe DNA in a stage-specific manner, suggesting 
that analysis of purified RBs should yield results comparable with intracellular events.  
However, it was not possible to isolate sufficient purified RBs that yielded EUO-
precipitable DNA earlier than 16 hpi.  Attempts to analyze RBs in fixed crude extracts at 
early times post infection yielded only host DNA bound to EUO, and attempts to 
eliminate host DNA from the extracts by treatment with DNase apparently eliminated 
EUO by proteolysis.   
There is no clear explanation for this phenomenon other than the contaminating 
proteolytic activity must be able enter RBs, perhaps damaged during lysis of the host 
cells.  In any event, data was obtained from 16 hpi that likely reflect events that took 
place before harvesting and purification, although this cannot be proven.  The 16-hpi RB 
analysis yielded results that were similar to previous, strictly in vitro studies:  binding 
was not specific for a particular region of the genome, binding was to ORFs rather than 
upstream regulatory regions (this may be a function chance; about 75% of the genome 
encodes ORFs), there was no stage-specific pattern to the bound ORFs, and no consensus 
sequence was identified within the binding fragments.  Taken together with the findings 
of previous studies, including those reported in Chapter 3, I conclude that the working 
hypothesis that EUO is a regulator of stage-specific gene regulation is incorrect.  What 
then is the function of EUO?  Here is a summary of what is known about EUO. 1)  It is 
encoded by the genomes all Chlamydia species and a highly homologous gene is found in 
proto-chlamydia that diverged from the genus Chlamydia about a billion years ago.  2)  
EUO protein is absent in EBs but the euo gene is one of the first and most actively 
expressed genes within 2 hours of infection.  3)  EUO continues to be made during the 
logarithmic phase of growth, but disappears late in the cycle.  4)  EUO is a minor protein 
which is never present in sufficient amounts to be clearly identified by Coomassie-stained 
gels.  5)  EUO binds to DNA in vitro.  6)  Binding is not confined to chlamydial DNA.  7)  
AT-rich sequences are preferred (not confirmed by my studies).  8)  Binding to 
chlamydial DNA in vitro is not random but is relatively non-specific.  9)  Binding of 
EUO to DNA in vitro is sufficiently tight to produce DNase footprints (Zhang, Douglas 
et al. 1998; Zhang, Howe et al. 2000).  10)  EUO binds to ORFs and intergenic regions.  
From these observations, I propose the following hypothesis:  EUO is not a stage-specific 
regulator of transcription per se but rather is a general DNA binding protein that 
facilitates transcription, somehow boosting transcription at the very beginning of the 
cycle through the logarithmic phase.  The limited number of EUO molecules per RB 
suggests that EUO does not facilitate transcription of all genes, but the relatively non-
specific binding suggests many genes are affected.  EUO is degraded sometime during 
the late phase, thus whereas it can bind to late gene sequences, it is not available to 
facilitate transcription of late genes.  My studies do not suggest a mechanism by which 
EUO may facilitate transcription, but the failure to detect binding specifically near 
promoters suggests that EUO does not function during initiation events.  Alternative 
functions for EUO will be discussed in the General Discussion chapter.  It is hoped that 
this loose model will serve to direct future studies on the function of EUO. 
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CHAPTER 5.    GENERAL DISCUSSION 
 
 
 Our current understanding of mechanisms by which stage-specific gene 
expression is regulated is reviewed in Chapter 1, but specifics remain largely unknown.  
My studies investigated chlamydial gene regulation by attempting to answer two 
questions: Do sigma protein levels throughout the cycle suggest regulation by the 
sequential protein expression of stage-specific sigma factors in a cascade fashion and 
what are the DNA binding sites to which EUO protein bind?  The transcription profiles of 
the three chlamydial sigma genes during the cycle have been reported, but the relative 
level of sigma proteins has not.  Plus, at least one well-known gene, hctB, is transcribed 
by alternative sigma factor 28.  The euo gene is one of the first and most actively 
expressed genes early in the cycle but is not transcribed late in the cycle and EUO protein 
is not present in EBs.  Previous studies found that EUO binds to DNA in vitro, but that 
binding, while not random, is relatively non-specific.  Therefore, I took a more global 
approach than previous studies to identify EUO binding sites in vitro and in vivo with the 
rationale that identification of sites might reveal the function of EUO. 
 
 
SIGMA FACTORS ROLE IN TRANSCRIPTIONAL REGULATION IN 
CHLAMYDIA 
 
 
Expression of the Sigma Factor Proteins 
 
 IFA and western blot studies were undertaken to examine the working hypothesis 
that analysis of sigma protein levels during the cycle may identify one or more sigma 
factors as a potential regulator of stage-specific gene expression.  The points in the cycle 
tested were 10 to 48 hpi.  Sigma 66, the major sigma was present at all times as expected.  
Also, its present late in the cycle supports the in vitro transcription studies of Fahr et al. 
(1995) that sigma 66 initiates transcription from several known late-stage promoters.  
Possibly because of the insolubility of recombinant protein, not one chlamydial gene has 
been confirmed by in vitro transcription studies to be regulated by sigma 54.  However, 
two potential sigma 54 promoters have been identified on the basis of predicted sequence 
similar to the bacterial sigma 54 consensus, and it has been suggested that sigma 54 is a 
late-phase sigma factor (Mathews and Timms 2000).  Whereas I found RB cytoplasmic 
sigma 54 protein levels, as detected by monoclonal antibodies, to be present late in the 
cycle, the protein is prominently present as early as 10 hpi and appears to be RB-specific 
at late times.  Therefore, I concluded that sigma 54 does not appear to be a stage-specific 
sigma factor, although regulation of unidentified late genes that are expressed in the late 
logarithmic phase cannot be excluded at this time.  In contrast, the pattern of expression 
of sigma 28 does suggest that it may play a role in early EB development.  Although 
protein can be detected as early as 10 hpi, levels peaked at about 16-24 hpi, at the time 
when late gene transcription is first detected, including the known sigma 28-transcribed 
gene, hctB.  In summary, my findings support a partial cascade pattern of chlamydial 
gene expression in that sigma 28 is best expressed when early late genes are transcribed. 
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 Future studies need to investigate aspects of sigma proteins that I did not address.  
Perhaps most notably, very early times points were not examined.  This could easily be 
accomplished by IFA studies.  Preliminary studies not reported here do indicate that 
sigma 28 protein is not detected in 4 hpi RBs.  Sigma 54, present in EBs (Figure 2-10) is 
present in infecting EBs, as detected by polyclonal serum and thus also found at 4 hpi 
(Sigma 54 was not detected in EBs by the monoclonal serum).  However, IFA staining at 
10 hpi (Figure 2-9) suggests the protein in EBs had undergone degradation and may not 
be functional.   Another aspect that requires more study is the time of expression of 
alternative sigma factor regulators.  Our lab does not have access to antibodies against the 
predicted known sigma 54 regulator, CtcB, the equivalent or NtrC (Koo and Stephens 
2003); thus, CtcB was not investigated.  As discussed in Chapter 1, in some bacteria, the 
activity sigma 28-like factors is regulated by a complex system of anti- and anti-anti-
sigma factors, some of which (RsbW, RsbU, and RsbV1 and V2) are encoded by 
chlamydial genomes.  Our lab has generated polyclonal antibodies to recombinant forms 
of these factors.  In studies not reported here, I found that W and U factors were difficult 
to detect by IFA and western blot (indecisive results were obtained).  Both V proteins 
were easily detected by both methods, but were present at all times post-infection and in 
EBs, a finding not offering much insight into how they might regulate sigma 54 in a 
stage-specific manner.  Moreover, two studies (Hua, Hefty et al. 2006; Karlinsey and 
Hughes 2006) suggest that the anti-sigma factor RsbW does not bind to chlamydial sigma 
28 (V, W, and U do interact as expected), casting doubt on the role of Rsb proteins in the 
regulation of sigma 28 in chlamydiae (see Chapter 1).   
 
 The scope of my study was to monitor the protein levels of the three chlamydial 
sigma factors during the cycle.  Clearly, the most important future study would be to 
monitor sigma factor activity during the cycle.  At present, the only approach to do this in 
chlamydiae would be to further develop in vitro transcription assays using extracts of 
RBs.  A second best approach would be to identify predicted promoters in silico, 
determine the time of expression of their cognate genes, and use recombinant sigmas 
factors in an in vitro transcription system to confirm predictions.  This approach is 
tedious but has been accomplished for several late genes (Yu and Tan 2003); however, 
recombinant sigma 54 activity has not been reported, perhaps because of its insolubility.  
A non-in silico approach to identify the promoters of each sigma factor would be to 
perform a ChIP-to-Chip analysis using recombinant sigma factors in a manner similar to 
what was done with recombinant EUO in this study (Chapter 3).  A limitation of this 
approach is that, with the exception of sigma 28-like factors, sigma factors tend to bind 
DNA non-specifically in the absence of the other RNA polymerase subunits.   
 
 
Detection of an Unknown Antigen with Sigma 54 Polyclonal Serum 
 
 An interesting observation of the sigma factor study was the detection of an 
antigen in the chlamydial outer membrane complex by the polyclonal sigma 54 serum.  
Assuming that the IFA results reflect reaction with some form of sigma 54 antigen, it is 
possible that the polyclonal serum recognizes a membrane-bound form of sigma 54 not 
recognized by the monoclonal antibody that only detects a cytoplasmic form of sigma 54.  
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If this speculation is correct, sigma 54 may be in the class of extracytoplasmic function 
(ECF) sigma factors.  As reviewed by Helmann (2002), ECF sigma factors contain a 
transmembrane protein that functions as an anti-sigma factor that binds and inhibits the 
cognate sigma factor. Upon receiving a stimulus from the environment, the sigma factor 
is released and can bind to RNA polymerase to stimulate transcription of its respective 
genes.  Similar to ECF sigma factors, sigma 54, in its inactive form, may be bound to the 
chlamydial membrane and when activated detaches from the membrane and translocates 
to the cytoplasm where it is able to bind RNA polymerase, thus allowing the expression 
of sigma 54 regulated genes. 
 
 Another explanation behind sigma 54 antiserum staining the chlamydial 
membrane is that the polyclonal serum cross-reacted with an unknown antigen located in 
the outer membrane of chlamydiae.  Western blot analysis using sigma 54 polyclonal 
serum revealed bands being detected at the top of the gel in the loading wells, possibly 
indicating a supra-molecular complex that is not capable of migrating into the gel (not 
shown).  Unfortunately, attempts to lower the polyacrylamide percentage of the gel to 
allow this complex to enter into the gel were unsuccessful.  If the sigma 54 polyclonal 
serum does cross-react with an antigen structurally unrelated to sigma54, how was this 
cross-reactive activity generated by using recombinant sigma 54 protein as the antigen?  
One possibility is that the rabbit raised antibodies to the adjuvant in the inocculum.  
Adjuvants contain complex wall substances from mycobacteria and Brown and Rockey  
(2000) speculated that an antibody was thusly generated in their lab that cross-reacts with 
peptidoglycan in the septum in dividing RBs.  It would seem unlikely that our polyclonal 
reacts with peptidoglycan in that peptidoglycan has not been identified in stoichometric 
amounts in EBs.  However, reaction with some other supra-molecular complex is 
possible.  Also, the insoluble nature of the recombinant sigma 54 used as immunogen, 
rather than adjuvant, may have generated antibodies that recognize three-dimentional 
antigens in the OMC.  The generation of this serum did, however, produce antibodies 
against sigma 54, based on the ability of the serum to detect recombinant sigma 54 on 
western blots.  Thus, the possibility that some complex form of sigma 54 is indeed 
located in the OMC and plays a structural role cannot be dismissed.  
  
 
BINDING STUDIES OF THE DNA-BINDING PROTEIN EUO 
 
 Previous studies clearly demonstrated that EUO binds to DNA in vitro in a non-
random fashion, but with little specificity.  The working hypothesis of the studies 
reported in Chapters 3 and 4 was that a global in vitro analysis of EUO binding and/or an 
in vivo analysis of DNA fragments bound by native EUO will identify strong and weak 
binding sites that will lead to a prediction of EUO function.  The genes and fragments 
identified in these studies largely confirmed the earlier studies: strong binding sites were 
randomly distributed throughout the genome and did not fall into any stage-specific or 
functional category.  Also, the binding sites did not allow the derivation of a consensus 
binding site.  Although my preconceived bias was that my studies would reveal a few 
sites upstream from either early and/or late stage genes (a bias implied in my working 
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hypothesis), my results did allow me to generate an alternative hypothesis for the 
function of EUO and to generate a very preliminary model for the function of EUO. 
 
 
Discussion of the EUO Model 
 
The model is preliminary and not directly supported by experimental evidence.  It 
was derived on the basis of what is known about EUO; mainly that it binds to DNA with 
relatively little specificity.  There is little information in the literature to provide clues as 
to how EUO might specifically function in this model.  Previous studies suggested EUO 
prefers AT-rich sequence beg the possibility that EUO may bind to bends and kinks in 
DNA to in some way promote transcription.  Also, one might expect EUO to bind 
preferentially to promoter regions that are AT-rich.  In fact, EUO produces a broad 
DNase footprint in the omcAB promoter region (Zhang, Douglas et al. 1998).  However, 
neither my studies nor those of Zhang et al. (2000) support preferential binding to 
promoters.  These findings notwithstanding, a peculiar aspect of many chlamydial 
promoters is an “AT box” between the -35 and -10 promoter elements that enhances 
transcription in vitro (Douglas and Hatch 1995; Tan, Gaal et al. 1998).  It is possible that 
EUO interacts in some way with AT boxes. 
 
Future studies to test the model will be challenging.  Surrogate studies in E. coli 
should be attempted but likely will be negatively impacted by the fact that recombinant 
EUO forms an inclusion body in E. coli, and even the small amounts of EUO that may be 
soluble in E. coli likely will bind non-specifically to DNA in a manner reminiscent of the 
chlamydial histone like proteins and be toxic.  In fact, the Hatch recombinant clone dies 
during the late logarithmic phase of growth.  Also, the functional interaction of EUO, a 
chlamydia-specific protein, with DNA may be peculiar to some aspect of chlamydial 
DNA or require a protein partner for function that is not in E. coli or that lacks the 
interactive motif.  More likely to succeed but still a major “tour-de-force” undertaking 
would be in vitro transcription studies.  Some of the problems associated with this 
approach include the insolubility of recombinant EUO, the lack of specific knowledge of 
DNA templates to be examined, the likely necessity to include either purified chlamydia 
RNA polymerase or functional recombinant proteins, and the possible need of as yet 
unidentified auxiliary proteins. 
 
 
EUO Protein Interaction with Other Proteins and Its Degradation 
 
In an attempt to identify EUO-interacting proteins that may be responsible for 
binding specificity, I performed immunoprecipitations from radioactively labeled extracts 
but results suggested that EUO did not possess a binding partner.  It is plausible that the 
sensitivity of the assay was not sufficient to detect binding partners.  If EUO does have a 
binding partner, it is conceivable that only a certain population of EUO molecules binds 
to the interacting protein at any particular time.  This assumption combined with the fact 
that EUO is a minor protein further diminishes the probability that a binding partner will 
be detected.  It is also possible that the addition of formaldehyde to the RBs cross-linked 
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EUO and its binding partner in a manner that would not allow for this complex to be 
immunoprecipitated.  To overcome these obstacles, two hybrid assays could be 
performed.  Using EUO as bait, one could scan a genomic library of chlamydial proteins 
in an attempt to identify any interacting partners.  Although this would negate the 
possibility that physiological conditions of the RB may play a role in EUO binding 
another protein, it would eliminate the dilemma of not having enough material to detect a 
possible binding interaction.   
 
  In my initial attempts to perform ChIP-to-Chip analysis, I cross-linked C. 
trachomatis serovar D extracts and immunoprecipitated EUO.  Using polyclonal serum, I 
was able to detect EUO in extracts, but a discrepancy in size was noted between the size 
of EUO seen in extracts and the size of immunoprecipitated EUO from these extracts.  It 
is possible the smaller species was a degradation product of the full-length protein.  EUO 
degradation could serve as a mechanism to regulate its function, and understanding the 
mechanisms for this enzymatic activity should be investigated.   
 
Although I was able to immunoprecipitate the larger species of EUO, I did not 
observe the smaller species being immunoprecipitated.  An explanation for the ability to 
immunoprecipitate the full-length species and not the degraded species of EUO is that 
during the immunoprecipitation, serum is able to bind the native conformation of the full-
length species and not the native conformation of the degraded species.  The reason for 
the detection of both species on the western blot is that the serum was capable of 
recognizing both species when denatured.  Interestingly, the immunoprecipitation of the 
full-length species did not result in the co-immunoprecipitation of DNA.  It is possible 
that the smaller species is the active form of EUO and is responsible for the binding of 
DNA.  Several proteins, such as caspases, require processing before becoming active, 
therefore, it can be conceived that EUO needs to be processed in order to bind DNA.  
Further analysis, such as southwestern blots using a known EUO binding region, the CRP 
operon, to probe C. trachomatis serovar D extracts would help in evaluating if the smaller 
species is the only species capable of binding DNA.   
 
It is curious that a possible degraded species of EUO was observed in extracts 
from C. trachomatis serovar D but was never been observed in C. trachomatis serovar L2 
or C. psittaci extracts.  The detection of the degraded species of EUO in the C. 
trachomatis serovar D extracts could be the result of varying antibody qualities between 
the serums but it could also be that this phenomenon is specific to C. trachomatis serovar 
D.  Comparing the genomes of Chlamydia spp. revealed the presence of species specific 
and serovar specific genes (Kalman, Mitchell et al. 1999; Shirai, Hirakawa et al. 2000; 
Read, Myers et al. 2003).  It is believed that the differences between the genomes may be 
responsible for the differences observed in their growth and tissue tropism of various 
species of Chlamydia.  The gene coding for EUO is present in each genome sequenced 
but factors that affect EUO’s activity may be species/serovar specific.  It can be 
speculated that the degradation of EUO may be specific for a particular species or serovar 
of Chlamydia and may be responsible for the differences in growth patterns or the ability 
to infect different tissues.   
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In Vitro Binding Specificity of EUO  
 
Primary DNA sequence may not be the sole determinant for EUO binding; rather, 
DNA conformation may be responsible for the affinity of EUO for particular regions of 
DNA.  Kim et al. showed that the conformational status of DNA was an important 
determinant for the sequence-specific binding of the tumor suppressor protein, p53 
(1997).  Another study has demonstrated the ability of a protein to bind particular regions 
of DNA without the requirement of sequence specific motifs altogether.  Gholer et al. 
mutated the DNA-binding domain of the tumor suppressor, p53, which disrupted its 
sequence specific binding characteristic but conferred it with the ability to bind specific 
structures of DNA (2005).  Therefore, analyzing sequence alone may not be sufficient in 
identifying the EUO DNA binding regions within the genome.     
 
If DNA structure is pivotal to the binding affinity of EUO, then the in vitro ChIP-
to-Chip analysis may not be capable of elucidating the regions of the chlamydial genome 
that EUO binds.  This method required the sheering of genomic DNA isolated from 
chlamydiae to small fragments that may alter or eliminate critical conformational 
structure.  It is known that DNA does take on different conformations throughout the 
developmental cycle (Solbrig, Wong et al. 1990), and investigators have shown that DNA 
structure does play a role in transcription (Barry, Brickman et al. 1993; Niehus, Cheng et 
al. 2008; Case, Peterson et al. 2010).  It has been noted that EUO introduces bends in 
DNA (Zhang, Douglas et al. 1998), but it is not known if its binding requires DNA to be 
in a particular structure.  
 
 
In Vivo Binding of EUO 
 
 Thirty genes were identified in my in vivo study.  Although no clear commonality 
could be discerned among the genes, a discussion of a few of them is worthwhile. The 
putative thiol:disulfide exchange protein, although not experimentally examined in 
Chlamydia, causes the oxidation and the reduction of a disulfide bonds (Holmgren 1989).  
The outer membranes of EBs are extensively cross-linked, but upon entering into their 
host cell, the EBs convert to RBs in which outer membranes are not cross-linked.  EUO is 
seen to be expressed early in the developmental cycle and absent in EBs.  From the ChIP-
to-Chip data, it can be speculated that the expression of EUO may play a role in the 
expression of the thiol:disulfide gene, thus causing the reduction of the outer membrane.   
 
clpB is another gene that may be regulated by EUO.  clpB, in other species, 
functions as a molecular chaperone that assists with the folding, assembly, and 
translocation of other proteins during high-temperature stress (Eriksson and Clarke 1996; 
Eriksson and Clarke 2000; Hong and Vierling 2000).  Increase in temperature results in 
chlamydiae entering into a persistent state (Kahane and Friedman 1992).  EUO 
transcripts are upregulated during an IFN-γ induced persistence (Ouellette, Hatch et al. 
2006) and may also be upregulated during heat-induced persistence, although this has not 
been verified.  It is possible that the increase in production of EUO can result in increased 
regulation of clpB, facilitating the ability for chlamydia to remain in a persistent state. 
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rsbV is a member of the partner switching mechanism that has been seen in other 
bacteria to help regulate the activity of the sigma factor, sigma B (Dufour and 
Haldenwang 1994).  Chlamydia spp. encode for two RsbV proteins designated as RsbV1 
and RsbV2 and both encoding genes are expressed throughout the developmental cycle 
(Douglas and Hatch 2000).  The regulatory function of the two RsbV proteins has not 
been elucidated although it has been noted that both RsbV1 and RsbV2 are capable of 
binding the anti-sigma factor RsbW (Hua, Hefty et al. 2006).  EUO was seen to bind the 
regulatory gene rsbV1 and not bind rsbV2.  Binding only one of the rsbV proteins may 
serve as a way to regulate the possible redundancy in function of these two similar 
proteins.   
 
 
EUO AS A POSSIBLE RNA CHAPERONE 
 
My studies examined the binding of EUO to DNA.  It is possible that EUO 
regulates genetic expression through binding to RNA.  Host factor Qβ (Hfq) is a DNA 
binding protein although its major role is to bind small regulatory RNA and facilitate 
their antisense interaction with its target.  Hfq was initially discovered as an essential 
factor for the replication of bacteriophage Qβ in E. coli (August, Eoyang et al. 1970).  
Since then, it has been discovered in Vibrio cholerae, Salmonella typhimurium, 
Pseudomonas aeuroginosa, Staphlycoccus aureus.  Hfq is essential for translation for the 
sigma factor RpoS in S. typhimurium (Brown and Elliott 1996).  It also has been shown in 
V. cholerae to be responsible for aiding the degradation of micX transcript in an RNase E-
dependent fashion (Davis and Waldor 2007).  Small regulatory RNAs have been 
described in Chlamydia (Abdelrahman, Rose et al. 2011), but Hfq is not encoded by 
chlamydial genomes.  Could EUO be an RNA binding protein with Hfq-like function?   If 
true, this would explain the promiscuous DNA binding nature of EUO, since RNA 
binding proteins can also bind to DNA.  The studies of Zhang et al. (2000) concluded that 
EUO does not bind to RNA, but this possibility needs to be re-examined more carefully.  
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